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Biliary diseases are uncommon, potentially fatal causes of acute abdomen in dogs. Little
information is present comparing the performance of computed tomography (CT) to ultrasound
in identifying canine biliary pathology. Thirty-five client-owned dogs presenting for acute
abdomen signs received an abdominal ultrasound and contrast-enhanced abdominal CT. Two
authors reviewed the randomized, anonymized CT and ultrasound studies. Twenty-eight dogs
had biliary pathology and seven dogs serving as controls had no evidence of biliary disease. The
final diagnoses of patients with biliary pathology included cholelithiasis, gallbladder mucoceles,
cholangiohepatitis/cholangitis, extrahepatic biliary obstruction, gallbladder wall edema,
gallbladder wall mass, and cystic mucosal hyperplasia. Computed tomography was more
accurate in identifying cholelithiasis than ultrasound. No statistical difference in the odds to
identify other biliary pathology was identified between ultrasound and CT. Findings from this
study suggest CT may be used in place of ultrasound in canine patients presenting for acute
abdominal signs of biliary origin.
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CHAPTER I
INTRODUCTION
Canine Hepatobiliary Anatomy
The biliary system consists of the gallbladder, the cystic duct, the bile duct, hepatic ducts,
inter- and intralobular ducts, bile ductules, and hepatic canaliculi.1 Hepatic lobules are small
polygonal functional units of liver parenchyma which are approximately 1 mm in diameter.2 The
hepatic lobules have a single curved sheets of cells in a single layer which enclose numerous
liver sinusoids, which are blood filled cavities that allow passive transport of intersinusoidal
blood.2 A single central vein is within the center of the hepatic lobules which is the origination
of the hepatic efferent blood flow.2 The central veins converge to form the intralobular veins
which then continue to fuse to form the hepatic veins.2 The hepatic veins then terminate within
the caudal vena cava.2 The portal vein delivers functional blood from the stomach, intestines,
pancreas, and spleen to the liver.2 Approximately 80% of the blood flow to the liver comes from
the portal vein with the other 20% being delivered from the hepatic arteries which contain
oxygenated blood from the aorta and celiac artery.2 The hepatic artery supplies much of the liver
framework, including the hepatic capsules, blood vessel walls, intrahepatic biliary duct system,
and nerves.2
The gallbladder is a saccular organ located within a fossa between the right medial and
quadrate lobes of the liver and connects to the bile duct via the cystic duct. The cranial aspect of
the gallbladder is a blind ended sac called the fundus or apex.2 The larger middle portion of the
1

gallbladder is the body.2 The caudodorsal aspect of the gallbladder tapers as it courses towards
the cystic duct and is called the gallbladder neck.2 The gallbladder stores and concentrates the
bile up to 10 times the initial concentration where it becomes dark brown to greenish brown from
the original golden yellow to orange color which is within the hepatic biliary system.1,2 The
gallbladder stores bile where it is concentrated, acidified, and modified between feedings.1
However, the gallbladder does not have an indispensable function as cholecystectomy is usually
well tolerated.1
The gallbladder wall structure and layering resemble the intestines as it is
embryologically derived from the gastrointestinal tract (Figure 1.1).1 Mucosa with microvilli
and surface epithelium outline the luminal surface which increases the surface area allowing for
resorptive and exchange processes.1 Also like the intestine, the gallbladder wall layers in order
from inner to outer: mucosal lamina propria (with a lymphoplasmacytic population, lymphatics,
and blood vessels), muscularis layer which aids in the expression of bile, layer of connective
tissue, and outermost serosa.1 Mucus glands within the gallbladder mucosa produce mucin that
protects the luminal surface epithelium from the cytolytic effects of bile acids.1 Mucin
production is stimulated by inflammatory cytokines, endotoxins, and prostaglandins.1 The
lymphatic vessels within the lamina propria may be grossly visible during portal hypertension,
chronic passive congestion, or hepatobiliary inflammation.1 Fluid leaked from the gallbladder
lymphatic vessels with these disease processes can cause gallbladder wall thickening which can
be observed ultrasonograpically.1
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Figure 1.1

Photomicrograph of a normal canine gallbladder. Adapted from Center SA.
Diseases of the Gallbladder and Biliary Tree, Veterinary Clinics of North America
- Small Animal Practice, 2009;39(3):543-598.

The cystic duct extends from the neck of the gallbladder to the junction of the first
tributary of the hepatic ducts (Figure 1.2).2 The bile duct then continues and receives other
hepatic ducts.1,2 The bile duct in a medium sized dog is 5 cm long and 2.5 mm in diameter.1
The free portion of the bile duct courses through the hepatoduodenal ligament as it extends from
the liver to the duodenum.2 The intramural portion of the bile duct tunnels through the
descending duodenal wall to terminate within the duodenum.2 The intramural portion of the
canine bile duct is 1.5–2 cm in length which terminates on a small hillock where the bile duct
opens centrally at a small rosette (Figure 1.3).2 In the dog, the bile duct then continues to
terminate within the major duodenal papilla via the bile duct sphincter (sphincter of Oddi) along
with the pancreatic duct, the smaller of the two pancreatic ducts.1,2 Because of the close
proximity of the pancreatic duct to the bile duct, pancreatitis is the most common cause of
extrahepatic biliary outflow obstruction.1 Approximately 3 cm distal to the major duodenal
papilla, the larger accessory pancreatic duct enters the descending duodenum at the minor
3

duodenal papilla.2 The sphincter of Oddi acts as a one-way valve allowing for unidirectional
flow of bile from the biliary system into the duodenum and provides protection against duodenal
contents travelling retrograde through the biliary tree.1 There is a double layer of smooth
muscle surrounding the intramural portion of the bile duct which allows the activity of the
duodenum to control a large portion of bile release in addition to gallbladder wall contraction.2
There is variability of these muscles in dogs as some have no muscles and some have 3 layers of
muscles.2

Figure 1.2

Anatomical relationship of the gallbladder, cystic duct, hepatic ducts, bile duct and
the major duodenal papilla within the descending duodenum. The pancreatic duct
also empties into the descending duodenum at the major duodenum. Adapted from
Miller’s Anatomy of the Dog, 4th ed. Evans H de LA, Elsevier, 2013.
4

Figure 1.3

A. The major duodenal papilla visualized within the descending duodenum in the
dog. The bile duct and pancreatic duct empty separately into the major duodenal
papilla in the dog. B. The intramural biliary duct within the duodenal wall with
encircling musculature. Adapted from Miller’s Anatomy of the Dog, 4th ed. Evans
H de LA, Elsevier, 2013.

The vagal nerve innervates the gallbladder and bile duct.2 The arterial blood supply to
the gallbladder and bile duct is provided by the cystic artery which is the left branch of the
hepatic artery.1 Having a single arterial source for perfusion makes the gallbladder and bile duct
susceptible to ischemic necrosis following blunt abdominal trauma leading to vascular shearing
or from biliary disease.1 Compromised perfusion and wall necrosis can lead to biliary rupture
and bile peritonitis.1
Bile is produced by sheets of hepatocytes surrounded by the blood sinuses and is excreted
into the bile canaliculi between the cells (Figure 1.4).2 Hepatocytes have a basolateral membrane
which contains microvilli that lines the space of Disse and are bathed in sinusoidal ultrafiltrate.1
The opposite hepatocyte membrane is the apical-polar (canalicular) membrane which
5

communicates with the bile canaliculi and contains transporters used to form bile.1 The bile
canaliculi are the site of initial bile formation and are 1 mm in diameter.1 The hepatic bile is
golden yellow to orange in color.1 The canalicular membranes contain tight junctions that
separate bile from sinusoidal blood and ultrafiltrate.1 Hepatic bile formation is categorized as
either bile acid-dependent or independent.1 The independent mechanism utilizes active
transportation of glutathione into the bile canaliculus with modification of the bile in the bile
ductal system.1 Canalicular bile formation is a continuous osmotic process mainly driven by
active transporter pumps within the hepatocytes excreting organic solutes including glutathione
and bile acids.1 This active process is then followed by passive excretion of water, electrolytes,
and nonelectrolytes (including glucose and amino acids) into the bile.1

Figure 1.4

Anatomy of the normal hepatic sinusoids, portal triad, and central vein. Hepatocyte
basolateral membrane contains microvilli that lines the space of Disse and are
bathed in sinusoidal ultrafiltrate. The opposite hepatocyte membrane (apical-polar
membrane) communicates with the bile canaliculi and contains transporters used to
form bile. The bile then travels to the bile duct and into the biliary system. Adapted
from Stellate Cells in Health and Disease, Gandhi CR and Pinzani M, Elsevier Inc,
2015.

6

Lipid vesicles are also detached from the apical membrane of the bile canaliculus which
form micelles.1 Mixed-micelles are bile salt anions and cations (either sodium or calcium)
aggregated with phospholipids, lecithin (also called phosphatidylcholine), and free cholesterol.1
The bile is maintained isotonic to plasma by the formation of mixed-micelles which also
decreases the bile's toxicity to the biliary epithelium.1
The salt-independent canalicular bile formation utilizes glutathione, the only endogenous
anion known to promote bile under physiologic conditions with the rate of secretion being
related to bile flow.1 Glutathione is strongly osmotic due to its hydrophylic composition, active
membrane canalicular exportation, and membrane-affiliated gamma glutamyl transferase
hydrolysis.1 The hyperosmolarity of glutathione causes water and electrolytes to dilute bile
through passive osmotic pathways.1
The function of bile is to deliver bile acids into the gastrointestinal tract to aid in lipid
digestion.1 Bile acids are amphipathic organic anions synthesized in the liver.1 Bile acids are
primarily conjugated within mixed micelles and circulate efficiently within the enterohepatic
circulation.1 Bilirubin glucuronides are hydrolyzed to unconjugated bilirubin with some being
resorbed back into systemic circulation.1 Normal bile contains less than 2% of bilirubin that is
unconjugated.1
Bile also functions to transport and ultimately eliminate lipophilic metabolic products and
xenobiotics.1 Xenobiotics are chemical substances that are not created in the patient including
plant constituents, medications, food additives, and pollutants.3 Cholesterol is also a common
constituent of bile. High concentrations of cholesterol within bile can increase the risk of
developing cholesterol choleliths, which are common in humans.1 Dogs do not have the same
cholesterol bile saturation as humans and therefore do not develop primary cholesterol
7

choleliths.1 This is important to consider when using ursodeoxycholate (a medication that helps
reduce the cholesterol saturation of bile and causes gradual dissolution of cholesterol-rich
choleliths) as a choleretic in dogs when medical management of choleliths is preferred.1 Since
canine choleliths do not have a high cholesterol composition, cholelith dissolution, which is well
reported in humans, is unlikely to occur.1
The hepatic canalicular bile travels continuously through the bile canaliculi which then
connect and continue as the bile ductules (Figure 1.5).2 The bile ductules then further combine
to form the plexiform of intralobular bile ducts which are within the interstitium between the
lobules.2 The intralobular bile ducts converge to form the interlobular bile ducts. The
interlobular bile ducts are part of the portal triad which also contains a branch of the hepatic
artery and a branch of the portal vein.2 The interlobular bile ducts then converge to form the
intrahepatic bile ducts (Figure 1.6).2 These ducts course within the hepatic parenchyma centrally
towards the bile duct.2 The intrahepatic interlobular bile ducts become the extrahepatic
interlobular bile ducts once they exit the hepatic parenchyma.2 The extrahepatic bile ducts
directly communicate with and terminate within the bile duct. Bile can then enter the gallbladder
to be stored or exit the bile duct via the sphincter of Oddi. Bile continuously enters the
gallbladder in a low-flow low-pressure system.1 Hepatic bile secretion and the tonic contraction
of the sphincter of Oddi create pressure within the biliary system promoting accumulation of bile
within the gallbladder.1

8

Figure 1.5

Anatomy of the hepatic lobule demonstrating the relationship between
hepatocytes, bile canaliculi, portal triad structures (branch of the portal vein,
interlobular bile duct, branch of the hepatic artery), and the central vein. Adapted
from Amboss.com.
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Figure 1.6

Hepatic and biliary anatomy including the gallbladder, hepatic bile ducts, cystic
duct, and bile duct. Adapted from Miller’s Anatomy of the Dog, 4th ed. Evans H
de LA, Elsevier, 2013.

Primary hepatic bile is modified during transportation through the biliary system by
secretion and reabsorption of fluid and inorganic electrolytes.1 Cholangiocytes, epithelial cells
that line the biliary tree, uptake bile salts via a sodium dependent transporter as the initial step in
the cholehepatic shunt pathway.1 This pathway allows intrahepatic recycling of bile salts
through a periductular capillary plexus which is important for signaling ductular mucin and
bicarbonate secretion into bile.1 The cholehepatic shunt pathway also contributes to the high
serum-bile acid concentrations in patients with cholestatic liver disease.1
Bile within the gallbladder is acidified by the absorption of sodium cations (Na+) in
exchange for hydrogen cations (H+) with concurrent passive transfer of potassium cations (K+)
10

and calcium (Ca2+) with plasma.1 Gallbladder biliary sodium bicarbonate (HCO3-) is neutralized
by hydrogen cations (H+) with additional excretion via circulatory carbon dioxide (CO2).1
Gallbladder motility is controlled by neuroendocrine signals, which coordinate this
motility with ingestion of food. 1 Glucagon stimulates canalicular bile formation and ductule
bicarbonate secretion.1 Vagal stimulation, cholecystokinin, and gastrin mildly stimulate hepatic
bile production.1 The presence of free fatty acids and amino acids and gastric distention
stimulate parasympathetic vagal stimulation, which in turn releases cholecystokinin and motilin
from the duodenum. This triggers gallbladder contraction and relaxation of the sphincter of Oddi.
Rhythmic contraction of the sphincter of Oddi regulates periodic duodenal bile release.1 The
relaxation of the sphincter of Oddi is also enhanced by secretin.1 Secretin also strongly
stimulates ductule bile flow which causes an increase in bicarbonate secretion by the gallbladder
mucosa producing a mucinous, bicarbonate-rich fluid that mixes with stored bile.1 Somatostatin
strongly inhibits bile secretion within the canalicular and ductular sites.1 The presence of
cholecystokinin also stimulates intestinal peristalsis, which helps to propel the bile salts to the
ileum.1 Within the ileum, the bile salts are recycled back into the enterohepatic circulation via
active transportation.1 With the previously discussed active transporters within the hepatocytes,
the enterohepatic circulation is a highly efficient system with approximately 5% of fecal loss per
day.1 Negative feedback from the bile salts returning to the liver then inhibits further
cholecystokinin release. Bile salt-dependent bile flow has a potent negative feedback effect at
the level of the canaliculus (which is a direct linear relationship), with non-micelle-forming bile
salts having the greatest effect.1 After the completion of meal-initiated gallbladder contraction,
the gallbladder relaxes and the sphincter of Oddi tone returns.1 The flow of bile then returns to
the hepatic bile diverting to the relaxed gallbladder for continued storage.1
11

Xenobiotics including erythromycin, glucocorticoids, rifampicin, phenobarbital, oltipraz,
and cisplatin can pharmacologically induce the release of motilin as well.1 Some of the
mechanisms of action of these drugs involve modulating bile formation at the canalicular level
by inducing transport pump activity via the multidrug resistance-associated protein-2 (MRP-2).1
The opposite occurs during cholestasis where the MRP-2 activity is down-regulated.1
Furosemide also has a choleretic effect (increase the volume of bile secretion) by inhibiting
active sodium transportation and therefore stimulating bile flow in canine patients but can
impose a detrimental effect in dehydrated patients.4 A canine study also showered
ursodeoxycholic acid (UDCA) and dehydrocholic acid induce choleresis as well.5 Oral UDCA at
50 mg/kg increased bile flow by 70% and increased the concentration of phospholipid,
cholesterol, bile acids, and bilirubin in bile within 1 hour of administration.5 Oral dehydrocholic
acid at 50 mg/kg also caused an increase in bile flow (270%) by inducing secretion of
electrolytes and water from the bile canaliculi.5
Canine Abdominal Imaging
A diagnostic approach in working up canine patients presenting with clinical signs related
to biliary pathology includes a complete physical exam, bloodwork including a complete blood
count and biochemistry, and diagnostic imaging. Common bloodwork abnormalities include
elevated liver enzymes (including alkaline phosphatase [ALP], alanine transaminase [ALT], and
gamma-glutamyl transferase [GGT]) and hyperbilirubinemia. If sepsis is present, a neutrophilia
with a left shift or a neutropenia may also occur. Diagnostic imaging remains an important tool
for patients presenting with acute abdominal pain, as it is often required not only to make a rapid,
accurate diagnosis, but also to decide if the patient requires surgical or medical treatment.
Traditionally, abdominal ultrasound (US) has been the gold standard in veterinary medicine for
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animals presenting for acute abdomen.6 This is in part due to the ability to eliminate visceral
superimposition (a problem in abdominal radiography), to delineate parenchymal detail, and to
better discern the presence of free abdominal fluid.7 In addition, the ultrasonographic features of
several conditions resulting in acute abdomen have been well described in dogs, including
pancreatitis and gastrointestinal disorders. In fact, US has been shown to improve detection of
gastrointestinal foreign bodies when compared to survey radiography.8 However, US is not
without its limitations, which include inter-operator variability and experience level, limited field
of view, long study time, potential patient discomfort, and potential lack of visibility of areas of
interest due to overlying bowel or free peritoneal gas.6 In addition, there is poor sensitivity of
US to pneumoperitoneum, a critical surgical lesion.6 Patient size is also a factor when
performing US. Previous authors determined that computed tomography (CT) detected a greater
number of lesions than US in patients weighing more than 25 kg.9 In humans, CT is the current
gold standard for imaging the acute abdomen, in part due to its relative speed of image
acquisition, improved contrast resolution as compared to radiography, and higher spatial
resolution than US.10–12 Many important abdominal structures have been well-described on
contrast-enhanced CT in the dog, including the liver, upper and lower urinary tract, spleen,
pancreas, gastrointestinal tract, adrenal glands, and hepatic and portal venous system.6,7
Importantly, however, little information is present in the veterinary literature describing the CT
appearance of biliary diseases presenting in dogs with acute abdominal signs. Computed
tomography would be an excellent alternative to an abdominal US when a sonographer trained in
evaluating the canine biliary tract is not available, especially in an emergency setting, as the
biliary tract is difficult to evaluate. Alternatively, CT studies can be performed quickly with
sedated patients by personnel with limited training where radiologists can interpret the studies on
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or off site and are becoming more common in veterinary hospitals. It is unknown whether CT is
as accurate as US to diagnose biliary diseases in these patients.
Canine Biliary Radiography
Abdominal radiographs have limited utility in diagnosis of biliary diseases as there is
border effacement of the gallbladder with the liver. Mineral opaque structures within the biliary
tree may represent cholestasis or dystrophic mineralization associated with congenital
malformations, chronic duct inflammation, or choleliths.1 Cholecystoliths are mineral opaque
stones within the gallbladder and choledocholiths are within the hepatic or cystic ducts or bile
duct (Figure 1.7). Choleliths with sufficient calcium bilirubinate will be radiographically
visible.1 A mass effect in the right cranial quadrant of the liver may represent a dilated
gallbladder in canine patients with extrahepatic biliary outflow obstruction.1 Additional
consideration for a mass effect within the right cranial abdomen includes pancreatitis, neoplasia,
or focal bile peritonitis. Radiographic evidence of abdominal effusion creating poor abdominal
serosal and soft tissue opaque whisps over the falciform and/or mesenteric fat may prompt early
diagnosis of bile peritonitis.1
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Figure 1.7

A radiograph of a feline patient with mineralization throughout the biliary system
including cholecystolithiasis, hepatolithiasis, and choledocholithiasis.

Another biliary pathology able to be identified radiographically is gas within biliary
structures or liver. Gas in these locations indicates an emphysematous process such as
cholecystitis, choledochitis, hepatic or biliary abscess, necrotic neoplasia, or necrotic
granuloma.1 Gas within the portal vasculature can also originate from emphysematous processes
in the intestines or spleen. Identification of gas within the biliary tree warrants percutaneous
ultrasound guided aspiration, surgical intervention, and/or antimicrobial therapy.1
Cholecystography can also be performed but is now rarely used due to the high
availability and better contrast and tomographic resolution of abdominal US and CT (Figure 1.8).
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However, radiographic contrast agents have been previously used and described for evaluation of
the biliary tree in dogs and cats.1 Cholecystography can be performed with iodinated contrast
administered orally, intravenously, or percutaneously into the gallbladder lumen. Distribution
and concentration of contrast agents for evaluating the biliary structures is influenced by
variables such as the presence of intraluminal material, hyperbilirubinemia, and bile or hepatic
duct occlusion.1 Cholecystography may identify choleliths, polyps, gallbladder intraluminal
masses, or gallbladder sludge, but is not able to confirm bile peritonitis or localize the site of bile
leakage.1

Figure 1.8

Example of percutaneous cholecystogram in a normal dog. c=cystic duct. cd=bile
duct. Adapted from Wrigley RH, Reuter RE. Percutaneous Cholecystography in
Normal Dogs. Veterinary Radiology. 1982;23(6):239-242.
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Fluoroscopic percutaneous cholecystography in normal dogs with a Chiba needle has
been described where contrast in injected directly into the gallbladder with the guidance of
fluoroscopy allowing for reduced risk of bile peritonitis and hemorrhage compared to blind
injection.13 In patients with biliary rupture, ultrasonically guided percutaneous cholecystography
allows for presurgical localization of the small gallbladder and the site of leakage.13 This
technique however is minimally used now due to advancements in ultrasonography and cross
sectional imaging.13
Canine Biliary Ultrasound
Abdominal ultrasound (US) is currently the gold standard method for biliary evaluation
in canine patients. Ultrasound can be used to subjectively estimate liver size, identify
parenchymal echogenicity changes, identify masses, evaluate for distension and wall thickness of
the biliary tree, size and echogenicity of the pancreas and perihepatic lymph nodes, and evaluate
for peritoneal effusion and peritonitis/steatitis.1 The gallbladder is pear-shaped in the
longitudinal plane and round in the transverse plane.14,15 The normal thickness of the gallbladder
wall in healthy dogs is 1-2 mm which is a thin hyperechoic line.1,15 Wall thickness can vary
depending on the degree of gallbladder distension.1 Artifacts such as reverberation and side
lobe artifact can cause the appearance of a thickened gallbladder wall (pseudo-thickening).
Pseudo-thickening of the gallbladder wall can also occur with peritoneal effusion surrounding
the gallbladder as a result of the acoustic interface between fluid and the gallbladder wall.1
Hyperechoic biliary sediment which is gravity dependent is typical for nonpathologic gallbladder
sludge.1,16,17 Finding gallbladder sludge is common in anorexic or fasted canine patients and
may be associated with cholestasis.18,19 Gallbladders sludge typically is not associated with a
distal acoustic shadowing unless there is a mineralized component.1 The echogenic material in
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bile represents conglomerates (1–3 mm) of calcium bilirubinate, cholesterol, and/or lipid droplets
suspended in the viscous mucin-rich phase of bile.1,18,20 The inability to identify the gallbladder
may be due to technical difficulties (including overlying gastrointestinal gas, pneumoperitoneum,
and body confirmation), gallbladder agenesis, or gallbladder rupture.1 Ultrasonographically the
cystic duct can be traced to the bile duct as it courses to the major duodenal papilla.1,15
Commonly the bile duct may not be identified in its entirety on US.1,15 When identified the bile
duct normally is less than 3 mm in thickness.1,15
The size of the gallbladder fluctuates depending on fasting, feeding, and disease
processes including cholestasis, gallbladder mucocele, and biliary outflow obstruction.1,14 A
canine cadaver study revealed the formula for human urinary bladder volume by Hakenberg and
others (1983) was most accurate to the actual gallbladder volume and volume was related to the
dogs’ bodyweight.14
Volume = L x W x

DT + DL
x 0.625
2

L = maximum length
DL = maximum dorsal to ventral depth in longitudinal section
W = maximum width
DT = maximum depth in transverse section

(1)

This study also concluded the two other formulas to calculate volume were also accurate.
The first formula uses the principle that the canine gallbladder is ellipse in shape with the
equation suggested by Finn-Bodner and others (1993):
Volume = 0.52 x (W x DT x L)
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(2)

The third equation is a formula for volume derived from regression analysis of the linear
ultrasonographic measurements:
Volume =– 30.2 + 6.08L + 10.6DL

(3)

Another study evaluated the time-related changes in gallbladder volume determined after
an overnight fast and sequentially after administration of a test meal plus or minus low-dose oral
erythromycin (motilin stimulus).21 Gallbladder volume was calculated by use of the same
ellipsoid equation:
Volume = L X W X DT X 0.53

(4)

Ejection fraction was calculated by:
Ejection fraction
= ([gallbladder volume at time 0 – gallbladder volume at specified time point]
/ gallbladder volume at time 0) X 100

(5)

If on initial abdominal US, a gallbladder is of less than or equal to 1 mL/kg body weight
and ejection fraction ≥ 25%, there is no need for motility assessment.21 The study also
concluded no treatment or time point was consistently superior as 20 of 22 (91%) dogs achieved
gallbladder contraction (maximal ejection fraction ≥ 25%) after ingestion of at least 1 treatment.
There were also no significant correlations between body weight and maximal ejection fraction
for any treatment. Lastly, the study concluded dogs with a gallbladder volume > 1.0 mL/kg and
ejection fraction < 25% may require a combined meal and erythromycin protocol.
A more recent study evaluated the use of three-dimensional (3D) US to evaluate
gallbladder lumen in canine patients.22 The study concluded that 3D US was able to accurately
estimate the gallbladder volume and fasting gallbladder volumes determined by 3D
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ultrasonography were significantly higher than the corresponding volumes determined by twodimensional (2D) ultrasonography. Also similar to the previous studies, gallbladder volumes
were significantly decreased in the postprandial state compared with the fasting state using 3D
ultrasonography, but 2D ultrasonography showed no significant difference.
Canine Biliary Computed Tomography
On computed tomography (CT), the normal gallbladder is ovoid to pear-shaped and
hypointense to the surrounding liver (Figure 1.9).23 As with US, the gallbladder size can vary
depending on the amount of bile it contains. While the wall of the gallbladder is not commonly
identified on unenhanced CT imaging, after the intravenous injection of iodinated contrast, a thin
line of enhancement can be seen along the wall, especially the portion that is adjacent to
peritoneal fat.23 Although the bile duct can sometimes be identified ventral to the portal vein, the
majority of the biliary system (especially the hepatic biliary ducts) is not consistently seen with
this modality.23 In one report, the bile duct was visible on CT in 68% of normal dogs, although
all dogs in this study weighed less than 15 kgs.24 This study also reported the estimation of
gallbladder volume and bile duct diameter with 3D rendering were not significantly different on
CT from those of the US. The bile duct diameter in these patients was not over 3 mm at the porta
hepatis and 3.5 mm at the duodenal papilla. The normal Hounsfield unit (HU) of bile has been
reported to be 34-35.8 HU.24,25
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Figure 1.9

Transverse computed tomography soft tissue window images with the left image
being precontrast and the right image being a venous postcontrast. The normal
gallbladder is ovoid to pear-shaped and hypoattenuating to the surrounding liver
(left image). While the wall of the gallbladder is not commonly identified on
unenhanced computed tomography imaging, after the injection of contrast, a thin
line of enhancement can be seen along the wall, especially the portion that is
adjacent to peritoneal fat (right image).

Meglumine iotroxate, brand name Biliscopin, is an iodinated intravenous contrast agent
which has increased hepatic metabolism allowing increased deposition of the contrast agent into
the hepatobiliary system. This contrast agent has been used for contrast enhanced CT
cholangiography for the evaluation of the canine, feline, and human biliary tracts with published
pathologies including canine gallbladder mucoceles.26,27 As biliary opacification requires normal
hepatobiliary function, contrast enhancement may be limited in patients with hyperbilirubinemia
(due to cholestasis or poor hepatocyte function), hyperproteinemia, or excessively dilated biliary
ducts. In these patients, renal excretion is increased. The use of Biliscopin is limited as the gold
standard for tomographic evaluation of the biliary system in humans is contrast enhanced
magnetic resonance imaging (MRI), and there is no FDA approval of Biliscopin in veterinary
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medicine in the United States. This limits the availability of Biliscopin to be used in veterinary
medicine.

Canine Biliary Scintigraphy
Biliary scintigraphy is available, but is very expensive, not commonly available, and
exposes the patient to ionizing radiation. This modality has been largely replaced by US, CT, and
MRI. Radioisotopes can be used for quantitative hepatic perfusion and biliary ejection
calculation using synthetic cholecystokinin infusion.28 Commonly used radioisotopes have short
half-lives, including technetium 99mTC and 99mTc-2,6 diisopropylphenylcarbamoylmethyl
iminodiacetic acid (DISIDA).1,28,29

Canine Biliary Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is not currently commonly used for evaluating the
canine biliary tract due to long study acquisition times requiring anesthesia, limited availability
of onsite MRI units, motion and respiratory artifacts, and the availability of a few published
reports on canine biliary MRI.30,31 Hepatobiliary MRI most commonly utilizes gadoxetic acid, a
hepatocyte-specific contrast agent.31 Gadoxetic acid (GD-EOB-DTPA) is a paramagnetic,
hydrophilic, ionic contrast agent and is utilized as one of the most useful MRI techniques to
diagnose liver tumors in humans.31 This contrast agent accumulates in functioning hepatocytes
following the arterial and venous phases (during the hepato-biliary phase) leading to hepatic
parenchymal enhancement.31 Due to the contrast not being taken up by metastatic cells or
nonfunctioning hepatocytes, this aids in the diagnosis of liver parenchymal metastases in
humans, differentiation of primary hepatic tumors, and diagnosis liver cirrhosis and focal nodular
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hyperplasia.31 A preliminary study found the MR images of proliferative hepatic parenchymal
lesions in dogs using gadoxetic acid are similar to those obtained in humans which suggests that
the contrast enhancement patterns used in human medicine may be useful in differentiating
hepatic parenchymal lesions in dogs.31
Magnetic resonance cholangiopancreatography (MRCP) is a newer technique used in
humans for the diagnosis of bile duct obstructions which does not require the use of contrast
agents or anesthesia.32,33 Endoscopic retrograde cholangiopancreatography (ERCP, a technique
that combines the use of endoscopy and fluoroscopy or radiography to evaluate the biliary and
pancreatic ductal system) is still the gold standard for evaluating the biliary and pancreatic
systems in humans as therapies can be performed concurrently, but is highly operator dependent,
has significant morbidity and mortality, and operators cannot cannulate the bile duct and
pancreatic duct in up to 9% of examinations.32–34 Alternatively, MRCP uses MRI to visualize
the biliary and pancreatic hyperintense fluid on T2-weighted images which improves spatial
resolution and allows for imaging of the entire pancreaticobiliary tract during a single breathhold.32 Although MCRP studies in dogs have not been described, MRCP may be a future
imaging modality to diagnose hepatobiliary disease in canine patients.30

Hepatobiliary Sampling
Cholecystocentesis is the aspirate sampling of gallbladder bile and can be completed
using a percutaneous ultrasound guided method, laparoscopic guidance, or during exploratory
abdominal surgery (Figure 1.10).35–37 Fluoroscopic guided percutaneous cholecystocentesis has
also been described but is used much less frequently due to the regular access to US which
allows for more accurate sampling and the patient not to be exposed to ionizing radiation.13 Bile
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samples are collected for cytologic evaluation and bacterial culture. A percutaneous transhepatic
approach or a direct fundic approach can be used.1 An advantage of the transhepatic approach is
the adherence of the gallbladder to liver in its fossa limits leakage from the puncture.1 If a direct
fundic approach is utilized, complete emptying of the gallbladder of bile to avoid spillage into
the peritoneal space is recommended.1 A study evaluating the percutaneous US guided
cholecystocentesis successfully used no chemical restraint and analgesia in their population of
dogs, but clinical patients may need mild sedation and/or local anesthesia to successfully
perform.36 This study also used 22-gauge needles to minimize physical damage and elicitation
pain.36
Complications of cholecystocentesis include hemorrhage, intraperitoneal bile leakage and
subsequent bile peritonitis, hemobilia, and bacteremia.1 Vasovagal reaction may also occur
which can result in ventilatory arrest, severe bradycardia, and death; so, clinicians should be
prepared to provide anticholinergics and ventilatory assistance during these procedures.1
Additionally, blunt pressure on the gallbladder provokes high vagal tone and should therefore be
avoided.1 In a study including three hundred percutaneous US-guided cholecystocentesis
procedures performed in 201 dogs and 51 cats, the overall incidence of major complications was
8 of 300 procedures (2.7%).38 Specifically, bile peritonitis occurred in only 2 of 300 procedures
(0.7%).38 Also identified within this study population, an ultrasonographically abnormal
gallbladder was found in 52% of cases and which had a sensitivity of 82%, specificity of 55.7%,
and accuracy of 61.5% to predict a positive bile culture.38 Consistent with other studies, this
study found a positive bacterial culture in 21.3% of the samples.38 When these findings were
compared, abnormal ultrasonographic findings were only a fair predictor of a positive bile
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culture, but did have an increased association of positive bile culture when there was concurrent
increased wall thickness and/or an irregular luminal surface on ultrasound.38

Figure 1.10

Sagittal ultrasonographic image of percutaneous transhepatic cholecystocentesis in
a dog. The dashed yellow line outlines the needle within the gallbladder.

Current Limitations in Canine Biliary Imaging
Although there are many reports describing the ultrasonographic features of gallbladder
disease in dogs, few reports exist in veterinary literature detailing the CT features of gallbladder
disease.24,25,27,39–41. Ultrasound findings indicating biliary disease include inspissated, nonmotile,
hyperechoic bile organized into a striated or stellate pattern, thickening of the gallbladder wall,
pericholecystic echogenic fluid or mesentery, dilation of the hepatic, cystic, or bile ducts, or
hyperechoic, distally shadowing structures within the biliary system.1,39,42 The normal
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gallbladder and bile duct appearance and size on CT have recently been reported, with the bile
duct measuring less than 3.5 mm in 50 normal dogs weighing less than 15 kgs.24 The largest and
most recent case series described confirmed gallbladder pathology in 34 dogs, which included
the first reported CT evaluation of a gallbladder wall hematoma.41
Computed tomography is the current gold standard for imaging the acute abdomen in
people. As the availability of small animal CT and specialist interpretation increases and the cost
of CT decreases, veterinarians will begin using this technology more to image animals presenting
with acute abdominal signs. Unfortunately, CT may be limited due to its higher cost, lower
availability, required use of general anesthesia or sedation, and use of ionizing radiation as
compared to US.
A few reports of other intraabdominal disease processes in dogs have also been published
which support CT as being equivalent or superior to abdominal US for evaluating these
pathologies. A recent retrospective descriptive study of 13 dogs found CT to have a higher
detection rate of canine gastric tumors as compared to ultrasound.43 Ultrasound identified 69%
of gastric tumors while CT identified 92% of gastric tumors, with a low percent agreement of
61.5%.43 Prior to this, abdominal US and endoscopy had been the imaging modalities of choice
for identifying and diagnosing gastric tumors in dogs.43 This study also found fair agreement in
the detection of abnormal lymph nodes on both CT and US with CT identifying more abnormal
lymph nodes.43 Within this patient population, leiomyomas located within the gastric cardia
were often missed on ultrasound most likely due to the craniodorsal location within the
stomach.43
Therefore, there is a critical need to further investigate the CT appearance of conditions
resulting in acute abdominal signs, notably those of the biliary system. The purpose of this study
26

is to describe the CT appearance of various biliary diseases in dogs and to compare the accuracy
of CT with abdominal US in the diagnosis of these diseases. This information can be used to aid
interpretation and hasten decision making in these critical patients.
Canine Hepatobiliary Disease
Biliary diseases are uncommon but potentially fatal causes of acute abdominal signs in
dogs. In dogs, biliary disease can occur secondary to cholelithiasis, gallbladder mucocele,
bacterial infection (cholecystitis), neoplasia, and various hepatic diseases. Extrahepatic biliary
disease can also result in a secondary biliary disease such as pancreatitis.1 The underlying
pathophysiology of biliary disease is usually attributed to cholestasis, which in turn predisposes
the animal to bacterial infection, choliths, and gallbladder mucoceles.12 With cholestasis, the
unabsorbable bile components, including bile salts, phospholipids, and cholesterol, are
concentrated and dehydrated by the resorption of water and electrolytes (sodium, chloride, and
bicarbonate).1 This leads to thickening of the bile and formation of inspissated, viscous, dark
green/black biliary material.1 Cocker spaniels and Shetland sheepdogs are reported to be
overrepresented breeds presenting for biliary disease, and affected animals tend to be older.1,39,44
In one study, the median age at time of presentation was 10 years.39 Unfortunately, clinical signs
of biliary disease are generally vague, and these animals often present with nonspecific
abdominal signs. In one report of dogs with biliary disease, the most common clinical signs
included vomiting, lethargy, anorexia, jaundice, fever, and abdominal pain.39 Biochemically,
canine patients may have elevations in ALP, GGT, and ALT and hyperbilirubinemia.1,39
Choleresis (enhanced bile flow) also can also cause biliary pathology by producing thin, dilute
bile.1 Choleresis is commonly a therapeutic goal in patients with cholestasis in large bile ducts.1
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A retrospective, multicenter, case series, descriptive study of 34 dogs is the only
descriptive publication which describes confirmed biliary pathology on CT.41 The final
diagnoses were confirmed with cytology, bile culture, surgical findings, and/or histopathology
within 1 month of imaging.41 The most common pathologies were cystic mucosal hyperplasia
(44.1%), gallbladder wall edema (26.5%), gallbladder mucocele (23.5%), bactibilia (20.6%),
cholecystitis (17.6%), white bile (17.6%), and cholelithiasis (11.8%). The presence of
intraluminal nodules, gallbladder wall thickening, hyperattenuating material (35-100 Hounsfield
units [HU]), and mineral attenuating material (>100 HU) were the most common abnormalities
detected.41 In this study, the gallbladder wall was best visualized on postcontrast images in 30 of
the 32 dogs (94%) that had both precontrast and postcontrast scans available.41 The median
precontrast bile was 37.6 HU (range 9.2-57.3 HU) and the median postcontrast bile was 43.6 HU
(range 3.6-57.1 HU).41 The bile duct was visible in 30 of 34 dogs with the entire duct being able
to be traced in 70% of the dogs.41 No CT findings have been identified as pathognomonic for
canine biliary pathology.41
Bile Characteristics
Normal HU of bile has been reported to be 34-35.8 HU.24,25 Hyperattenuating material
within the bile ranges from 35-100 HU, and mineral attenuating material is characterized by
being >100 HU.41 Cystic mucosal hyperplasia, gallbladder mucocele, gallbladder wall edema,
bactibilia, cholecystitis, and cholelithiasis are pathologies most commonly associated with
hyperattenuating material.41 Hyperattenuating material occurs predominantly in pathologies that
cause mucin production such as cystic mucosal hyperplasia and gallbladder mucoceles.41 It has
been hypothesized that this hyperattenuating material may be due to mucinous material as it is in
both the gravity dependent portion and suspended locations within the gallbladder lumen.41
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Similar suspended hyperattenuating luminal contents were noted in dogs with gallbladder
mucoceles on CT.25 Hyperattenuating material less commonly occurred in dogs with gallbladder
wall edema, bactibilia, and cholecystitis.41
Gallbladder Sludge
Biliary sludge is gravity dependent hyperechoic variably particulate material without
acoustic shadowing which may be within the gravity dependent portion (most commonly),
suspended, or solid appearing (Figure 1.11).18 In human patients, biliary sludge is a mixture of
cholesterol crystals, bile pigments, and bile salts which are embedded in mucin and often
includes particles ≥1 mm (microliths), which likely precede cholecystolith formation.18 The
composition of spontaneous canine gallbladder sludge has not been reported, but lower incidence
of canine cholecystoliths compared to humans suggests that canine sludge likely has a different
composition or etiology.18 Support from previous experimental studies indicates canine biliary
sludge does not contain substantial amounts of cholesterol.18,45–47

Figure 1.11

A canine patient with gallbladder sludge on ultrasound. This is a longitudinal
ultrasonographic image.
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A previous study analyzed the components of 43 samples of canine gallbladder contents
(21 with biliary sludge and 22 with gallbladder mucoceles) with infrared spectroscopy with 41 of
the samples also undergoing bacterial culture.20 The resultant infrared spectra were compared
with that of swine mucin. The contents of 20 (95.2%) biliary sludge and 22 (100%) gallbladder
mucocele samples exhibited similar infrared spectra as swine mucin. The study concluded the
gallbladder principal components in both biliary sludge and gallbladder mucoceles were mucins,
which suggested the possibility that mucins were involved in the pathogenesis of not only
gallbladder mucoceles but also biliary sludge.20 Although biliary sludge and gallbladder
mucocele contents exhibited similar infrared spectra, one sample of biliary sludge (4.8%) was
determined to be composed of proteins. The rate of bacterial infection of the gallbladder was
10.0% for biliary sludge and 14.3% for gallbladder mucoceles with almost all of the identified
bacterial species being intestinal flora. The route of biliary infection in this study was most
likely an ascending infection from the duodenum with both biliary sludge and gallbladder
mucoceles exhibiting low rates of bacterial infection of the gallbladder.20 The study suggested it
is possible that gallbladder mucoceles and biliary sludge have the same pathophysiology and
could represent a continuous disease process.20 It has been reported that sometimes there is no
clear distinction between the findings of severe biliary sludge and gallbladder mucoceles, which
makes their differentiation challenging.20,48
The clinical implication of canine gallbladder sludge is unclear.17 Echogenic
intraluminal gallbladder material is common and was identified in two-thirds of canine patients
undergoing routine abdominal ultrasound examinations.18 An early study suggested a weak
association between the presence of gallbladder sludge and patient age but did not identify a
connection to the presence of hepatobiliary disease.17 This study then concluded that canine
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gallbladder sludge should be considered an incidental finding.17 However, a later study found
mobile sludge or precipitate in 24 of 45 dogs with gallbladder disease with 9 of these 24 (37.5%)
having gallbladder ruptures.39 More recently, another study concluded that abnormal gallbladder
contents (both sludge and gallbladder mucoceles) in dogs were associated with decreased
gallbladder emptying following a meal challenge.19 This study did not, however, determined if
decreased gallbladder contractility was the cause or consequence of the abnormal contents.18,19
Biliary sludge has been iatrogenically induced in dogs by acute cystic duct ligation and dietary
manipulation.45,46 In both studies, the gallbladder sludge consisted primarily of bilirubinate and
mucin with some being complexed with calcium carbonate. Further, in a Shetland sheepdog
with a gallbladder mucocele, the gallbladder material had a similar composition to the
experimentally induced sludge.44 However, as this breed has a strong genetic predisposition for
defective phoshatidylcholine secretion and subsequent mucocele formation, this finding may not
reliably reflect events in other breeds.18,49
Canine patients with hyperadrenocorticism and hypothyroidism have been shown to be
associated with increased occurrence of gallbladder sludge and gallbladder mucocele
formation.50 This finding suggests a link between or precession of the presence of biliary sludge
and the development of a gallbladder mucocele.18,50 This theory has not been proven, but
gallbladder sludge has been reported around or embedded within gallbladder mucoceles.18,51 In
an experimental study, glucocorticoids (oral administration of hydrocortisone 8 mg/kg by mouth
twice daily for 3 months) have been shown to alter bile acid profiles in dogs as the bilirubin,
cholesterol, and calcium concentrations reversibly decreased during treatment.47 In a similar
separate study, hydrocortisone administration (at 8.5 mg/kg by mouth twice daily for 84 days)
caused reversible shifts toward higher concentrations of the more hydrophobic unconjugated bile
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acids (chenodeoxycholic acid and deoxycholic acid) and toward lower concentrations of the
amphipathic taurine-conjugated bile acids in gallbladder bile.52 These changes may impact
gallbladder epithelial function and mucus production. While gallbladder sludge pathophysiology
is not fully understood, it is often treated with a low-fat diet and medications, such as
ursodeoxycholic acid and S-adenosylmethionine.20
Mineral Attenuating Intraluminal Gallbladder Material
Mineral attenuating material is characterized as any material >100 HU.25 Mineral
attenuation material was the most common CT finding of the most recent study evaluating cases
with confirmed various biliary pathologies.41 Cystic mucosal hyperplasia, gallbladder mucocele,
cholelithiasis, white bile, and wall edema were the most common pathologies associated with
mineral attenuating material.41 All of these pathologies except for gallbladder wall edema are
associated with cholestasis and/or dysfunction of the gallbladder, which may alter the gallbladder
resorption of bile salts, mucin, and electrolytes that promote cholecystolithiasis formation.41
This study suggested that dogs with gallbladder wall edema develop mineral attenuating
intraluminal material likely secondary to other concurrent gallbladder pathologies like
cholecystitis and gallbladder mucocele, as they commonly occur simultaneously.41 Both this
study and a previous study evaluating canine gallbladder mucocele on CT reported a common
central distribution of the intraluminal mineral material in approximately 67% of cases.25,41 This
material identified on CT appears as hyperechoic material which displays distal acoustic
shadowing on US. If this material is not sufficiently mineral opaque and dense enough to change
the attenuation of the x-ray beam, it will not be identified on radiographs unless a large amount
accumulates together.
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Cholelithiasis
Cholelithiasis is the presence of mineral structures within the biliary tree including the
intrahepatic bile ducts (hepatolithiasis), large hepatic ducts, cystic duct (choledocholithiasis), bile
duct, sphincter of Oddi, and gallbladder (cholecystolithiasis). Cholecystolithiasis is the most
common type of cholelith and can be commonly identified on routine abdominal US in both dogs
and cats as most choleliths in small animals do not cause clinical signs.1 Both mineral
attenuating and radiopaque choleliths are identified with US as hyperechoic structures which
display distal acoustic shadowing and twinkle artifact when of sufficient size and density.1
Many small choleliths do not contain enough mineral for detection on survey radiographs.1
Choledocholiths within the bile duct or cystic ducts can be challenging to ultrasonographically
identify due to adjacent visceral structures, overlying gastrointestinal gas obscuring detection,
and because they are not surrounded by anechoic bile.1 Cholecystoliths are commonly mobile
and gravity dependent and can be differentiated from mural lesions by demonstrating this
gravitational mobility.1,18
The composition of choleliths in dogs differ than those in humas which are primarily
derived from cholesterol crystallization.1 Most canine choleliths contain calcium carbonate and
bilirubin pigments, earning the name ‘‘pigment gallstones.’’1 There are two categories of
pigment gallstones: ‘‘black-pigment’’ stones composed primarily of bilirubin polymers and
‘‘brown-pigment’’ stones composed primarily of calcium bilirubinate.1 Black-pigment stones
are formed during prolonged hyperbilirubinemia where bilirubin polymerization occurs after
nonenzymatic deconjugation.1 Brown-pigment stones commonly develop during cholecystitis
and cholestasis.1 In patients with cholecystitis, bilirubin deconjugation by bacterial bglucuronidase creates unconjugated bilirubin that precipitates as calcium bilirubinate.1 Biliary
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precipitates and pinpoint calculi promote bacterial colonization by providing a surface for
bacterial colony adherence which further promotes calcium bilirubinate aggregate formation.1
Local inflammation and prostaglandins (especially with cholecystitis and hemorrhage) promotes
mucin production which accumulates calcium bilirubinate and bilirubin polymers into cholelith
aggregates.1 This process is additionally enhanced by gallbladder dysmotility and cholestasis.1
Obstruction of the canine cystic duct increases gallbladder mucin production, cholesterol
concentration, and formation of pigment sludge.52 Each of these products favors cholelith
precipitation. First mucin-bilirubin complexes form then sludge particles (1–4 mm in diameter)
coalesce and precipitate as gravel and choleliths with increased mucin production.1 Gallbladder
distension from any etiology stimulates local mucin production which can cause the cystic duct
to occlude by initiating a self-perpetuating cycle involving biliary sludge accumulation and
inspissation.1 Patients with cholelithiasis must be evaluated to determine if the underlying
etiology requires interventional therapy.1
Obstructive cholelithiasis is characterized by the presences of clinical signs (most
commonly vague acute abdominal signs), finding a dilated bile duct on US or CT, and high liver
enzyme activity (especially ALP and GGT) and hyperbilirubinemia on a biochemistry.1
Obstructive cholelithiasis is more common in middle-aged to older dogs with a higher incidence
in small breed dogs and one study identifying an increased incidence in Miniature Schnauzers
and Miniature Poodles.1,52 Surgical intervention is commonly required to treat patients with
obstructive choledocholithiasis which usually involves cholecystectomy and lavage of the bile
duct.1 Some patients benefit from temporary bile duct stent placement to allow healing of the
surgical site, ensure bile drainage into the duodenum, and decrease risk of bile duct stenosis
during recovery, but this is not as commonly performed.1 A more intricate
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cholecystoenterostomy should be performed in patients with irresolvable obstructive
choledocholithaisis.1
Hypoattenuating Intraluminal Gallbladder Material
Lower bile HU (consistent with fluid attenuation) in dogs is consistent with decreased
bile density, most commonly identified with bactibilia.40 The suspected explanation for lower
bile HU is that gallbladder inflammation (as with bactibilia and cholecystitis) alters the
gallbladder ability to absorb water and therefore diluting the bile.41 Cholecystitis can occur from
infectious etiologies or extrahepatic biliary outflow obstructions.
Gallbladder Mural Neoplasia
Neoplasia of the gallbladder wall is uncommon in the dog but can be routinely identified
on US and CT as focal wall thickening or mass with increased blood flow on color and power
Doppler interrogation, strong contrast enhancement, and concave deformation of the gallbladder
lumen. Biliary carcinoid tumors have strong arterial contrast enhancement that wash out by the
delayed phase (HU arterial 136, HU delayed 71).40 Adenomas or adenocarcinomas are less
common and appear as an irregular and focal wall thickening.1 Larger pedunculated masses can
cause gallbladder outflow obstruction due to cystic duct occlusion.1 Sessile or polypoid lesions
in the gallbladder may be also be identified in dogs with gallbladder cystic mucosal hyperplasia
which can appear similar to neoplasia.1 A single case of canine gallbladder lymphoma (diffuse
large B-cell lymphoma) has been reported in a 7-year-old, spayed, female miniature dachshund
presented for progressive anorexia and icterus (Figure 1.12).53
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Figure 1.12

Ultrasonography of a canine patient with confirmed lymphoma. White arrow
shows the hyperechoic thickened gallbladder wall and the white arrowhead
outlines the hyperechoic gallbladder sludge. Adapted from Nagata N, Shibata S,
Sakai H, et al. Gallbladder lymphoma in a miniature dachshund. Journal of
Veterinary Medical Science. 2015;77(1).

Cystic Mucosal Hyperplasia
Cystic mucosal hyperplasia (CMH) appears as polypoid or sessile mural thickening with
mucosal margin undulation on US and CT and can also have a nodular CT appearance.1 Cystic
mucosal hyperplasia is commonly present in dogs with gallbladder mucoceles.1,40 Some dogs
with bactibilia have gallbladder wall nodules likely due to underlying cholecystitis.40
Histopathologically, CMH gallbladder mucosa has many cystic sessile or polypoid hyperplastic
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lesions that accumulate mucin within cystic structures and between polypoid villi (Figure 1.13).1
Commonly there is no evidence of inflammation, and the serosal surface remains intact.1

Figure 1.13

Pictomicrograph of a canine gallbladder with a gallbladder mucocele and cystic
mucosal hyperplasia. The mucosal wall is thickened and undulating with
entrapped mucus. Adapted from Center SA. Diseases of the Gallbladder and
Biliary Tree, Veterinary Clinics of North America - Small Animal Practice,
2009;39(3):543-598.

White Bile
White bile is the name of bile without bilirubin pigments, therefore causing the bile to be
colorless.54 Bile or cystic duct obstruction as with cholelithiasis and chronic extrahepatic bile
duct obstruction due to pancreatitis or a mass effect can produce a white bile syndrome when bile
containing pigment is separated from bile in the large ducts.1
Cholecystitis
Cholecystitis is defined as inflammation within the gallbladder. The inflammation may
be from nonsuppurative or suppurative processes and can be associated with infectious
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etiologies, systemic disease, neoplasia, blunt abdominal trauma, or gallbladder obstruction by
occlusion of the cystic duct.1 The presence of cholecystitis can modify bile composition and
alter bile flow by increasing ductular secretions of bicarbonate and mucin.1 In a normal biliary
tree, majority of the bile acids are conjugated while in patients with bactibilia or decreased bile
pH from local inflammation can result in bile acid deconjugation.1 Unconjugated bile acids are
cytotoxic, alter permeability of vascular structures, and induce further tissue inflammation likely
contributing to epithelial edema in patients with septic cholecystitis and choledochitis.1 Patients
with cholecystitis commonly have symmetric or asymmetric thickening of the gallbladder wall
which can be identified on US and CT.1 One patient with cholecystitis and bactibilia has been
reported to have strongly arterial enhancing nodules in the gallbladder similar to those of
neoplasia (especially carcinoid tumors).40
Cystic and bile duct occlusion causes biliary tree inflammation secondary to cholestasis
which then can be perpetuated by mechanical irritants such as choleliths.1 Also with cystic duct
occlusion, the gallbladder volume decreases due to occluded inflow of bile, the wall thickens,
and white bile forms.1 Gallbladder dilation occurs with more distal biliary outflow obstruction
within the bile duct due to increased backflow into the gallbladder. If gallbladder distention is
severe, wall ischemia can occur with subsequent necrotizing cholecystitis and increased risk of
gallbladder rupture.1 Acute septic cholecystitis can also occur with bactiblia.1
Symmetric or asymmetric gallbladder wall thickening, dilated bile, cystic, and/or hepatic
ducts, double-layered gallbladder wall, hypoechoic gallbladder wall, hyperechoic gallbladder
material, and choleliths are common findings with cholangitis identified on US or CT
evaluation.1,36,40 Diffuse hyperechogenicity of the gallbladder wall on US may also be
observed with gallbladder wall mineralization secondary to chronic cholecystitis.1 Abdominal
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radiography may show decreased cranial abdominal serosal detail consistent with focal
peritonitis.1 A sentinel loop (a single loop of gas dilated small intestine) may implicate a focal
ileus on radiographs.1 Occasionally the gallbladder wall may become mineral opaque due to
dystrophic mineralization secondary to chronic inflammation.1
Clinical signs of acute cholecystitis include abdominal pain, fever, vomiting, lethargy,
ileus, and jaundice.1 A complete blood count can include a leukocytosis with or without toxic
neutrophils and a left shift.1 Hyperbilirubinemia may be present and is associated with jaundice
depending on chronicity, involvement of extrahepatic biliary structures, presence or extent of
biliary tree occlusion, or bile peritonitis.1 Biochemistry findings include elevated liver enzyme
activity (ALT) with moderate to marked cholestatic enzymes (ALP, GGT) elevation.
Necrotizing Cholecystitis
Necrotizing cholecystitis involves ischemia and devitalization of the gallbladder wall
secondary to sever and/or chronic cholecystitis.1 Necrotizing cholecystitis often appears as an
asymmetric focal trilamination, discontinuation, or thickening of the gallbladder wall on US or
CT and often has concurrent adjacent small volume of peritoneal effusion and hyperechoic fat
(omental adhesions, chemical peritonitis, and/or gallbladder rupture and bile peritonitis).1
Gallbladder rupture and bile peritonitis requires prompt surgical intervention, most commonly a
cholecystectomy with potential biliary diversion.1 A common cause of necrotizing cholecystitis
is interrupted perfusion from the cystic artery by thromboembolism, a shearing tear delivered
from blunt abdominal trauma, bacterial infection, cystic duct obstruction (choleliths, neoplasia),
mature gallbladder mucocele causing wall ischemia, or extension of adjacent hepatic
inflammatory processes or neoplasia.1,40
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Emphysematous Cholecystitis and Choledochitis
Emphysematous cholecystitis and choledochitis is gas within the wall or lumen of the
gallbladder or segments of the biliary tree.55 In dogs this has been associated with diabetes
mellitus, acute cholecystitis with or without cholecystolithiasis, obstructive cholecystolithiasis,
traumatic or thrombotic ischemia, mature gallbladder mucocele formation, neoplasia,
incompetent sphincter of Oddi, and occlusion of the cystic artery.55,56 Emphysematous
cholecystitis is rare and can be caused by gas producing bacteria, most commonly Clostridium
perfringes and Escherichia coli.56 Clostridium perfringes has been identified as the cause of
acute abdominal signs in a dog with subacute severe necrotizing emphysematous cholecystitis.56
Emphysematous cholecystitis is a life-threatening condition which can be fatal without early
treatment with possible need for surgical intervention (most commonly cholecystectomy) due to
the high risk for gallbladder rupture and sepsis with concurrent antimicrobial therapy based on
culture and sensitivity of bile and affected biliary tissues.1,56
Emphysematous cholecystitis can be diagnosed radiographically as a spherical to ovoid
shaped gas opaque structure in the region of the gallbladder which may have fluid-gas interface
on horizontal beam projections.56 Other differential diagnoses for gas filled structures with this
appearance include hepatic or perihepatic abscess, liver lobe torsion and entrapment, biliaryenteric fistula, duodenal gas, incomplete sphincter of Oddi, and gallbladder lipomatosis.56

A

case report of a dog with a gas filled gallbladder on radiographs had a possible infarcted
gallbladder wall neoplasm (most likely round cell in origin) with a concurrent Clostridium
perfringens detected on bacteriologic culture.55
Ultrasonographic findings of emphysematous cholecystitis include those described with
cholecystitis in addition to reverberation or ringdown artifact of the mural or intraluminal
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gallbladder gas.56 This appearance may be difficult to differentiate from intramural
mineralization when a small volume of gas is present.56 When gas is within the lumen or wall of
the gallbladder, complete evaluation of the gallbladder and deeper structures is markedly limited
on abdominal US due to the reverberation artifact which inhibits the value of this modality.
Computed tomography helps bridge this gap as it can allow for direct visualization of the gas
location within the hepatobiliary system where gas bubbles can commonly be seen in linear
configurations.56,57
Parasitic Biliary Infections
Infection with liver flukes (trematodes of the Opisthorchiidae family) in endemic regions
can cause acute and chronic cholangitis in cats and occasionally in dogs.1,58 Liver fluke life
cycles require two intermediate hosts, a fresh water snail and a secondary host (such as a fish,
reptile, or amphibian) in which metacercaria encyst.1 The dog or cat tertiary host ingests the
flukes by eating the secondary host.1 Young flukes develop in the small intestines and migrate
into the bile tree where they mature within 8-12 weeks.1 Embryonated eggs pass from bile back
into the duodenum and may be detected on fecal exams as early as 12 weeks after infection.1
Fecal examination may fail to detect eggs due to sporadic passage, variable morphology, small
egg size, and development of bile duct obstruction that precludes passage of eggs into bile and
feces.1 Cholecystocentesis can also occasionally identify fluke eggs in bile.1
Patients may be asymptomatic with some having progressive clinical signs including
weight loss, anorexia, vomiting, diarrhea, jaundice, hepatomegaly, abdominal distention, and
death in severely affected patients.1 Some symptomatic feline patients resolve clinical signs
within 24 weeks after infection without treatment.1 Additional bloodwork abnormalities from
those commonly found with cholangitis may include an eosinophilia between 3-14 weeks after
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infestation which may persist.1 Patients with severe chronic cholangitis can develop biliary
fibrosis.1 The hepatic parenchyma usually remains normal and regional lymphadenopathy can
develop.1
Treatment for liver flukes includes antiparasitic therapy such as praziquantel (20 mg/kg
subcutaneously every 24 hours for 3–5 days) when infection is suspected.1 Fluke eggs may
continue to pass in feces for up to 2 months after successful treatment.1
Gallbladder Wall Edema
Gallbladder wall edema is the accumulation of fluid within the gallbladder wall causing
subsequent wall thickening. A double-rim sign may reflect gallbladder wall edema associated
with anaphylaxis, passive congestion due to right sided congestive heart failure or cardiac
tamponade due to pericardial effusion, portal hypertension, severe hypoalbuminemia,
cholecystitis, sepsis, biliary outflow obstruction, dexmedetomidine administration, blood
transfusions, and immune mediated hemolytic anemia.1,59–61 Gallbladder wall edema can also
occur with previously discussed pathologies such as infectious etiologies (bactibilia or systemic
infections), systemic inflammatory etiologies, or focal inflammatory etiologies such as hepatitis,
pancreatitis, peritonitis, and peritoneal metastatic neoplasia (such as carcinomatosis).
Gallbladder Mucocele
A gallbladder mucocele is an accumulation of green-black, tenacious, and immobile bile
and mucus which causes gallbladder distension, cystic mucosal hyperplasia, cholangitis, and
biliary outflow obstruction if the material extends into the cystic, hepatic, and bile ducts.62 The
presence of a large gallbladder filled with hyperechoic nongravitationally dependent material (an
immobile stellate, radial, or kiwi fruit appearance) and a hypoechoic ‘‘rim sign’’ are consistent
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with a gallbladder mucocele on US (Figure 1.14).1,18,20,41,63,64 Canine gallbladder mucoceles on
computed tomography have been reported to have a common central distribution of the
intraluminal mineral material in approximately 67% of cases with gallbladder wall distension
(Figure 1.15).25,41 This pattern demonstrates the dense central gallbladder conglomerate
comprised of thick sludge with mucin that is tightly adhered to the gallbladder mucosa
(hypoechoic rim sign).1,41 Some gallbladder mucoceles have a mixed echogenic, mosaic-like
appearance on US.41 So while there is a variety of ultrasonographic appearances to gallbladder
mucoceles, the key to diagnosis is that the luminal contents are not gravitationally dependent and
the gallbladder is distended.41,65,66 Consideration for a gallbladder mucocele is warranted when
sequential US examinations fail to identify a reduction in gallbladder size or content after
feeding.1 Additionally, the hepatic parenchyma is often hyperechoic because of coexistent
vacuolar hepatopathy or hypoechoic if acute hepatitis is present.41,43,64 Progressive gallbladder
distention may lead to necrotizing cholecystitis.
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Figure 1.14

Canine gallbladder mucocele on ultrasound, in sagittal view. The gallbladder is
markedly dilated with suspended hyperechoic material. The gallbladder wall is
thickened and hypoechoic. The surrounding mesentery is hyperechoic consistent
with surrounding peritonitis and steatitis.

Figure 1.15

Canine gallbladder mucocele on computed tomography (precontrast computed
tomography image in a soft tissue window). Gallbladder mucoceles typically cause
gallbladder wall dilation and central mineral attenuating material.
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Mucins are important in the development of gallbladder mucoceles. Mucins are a type of
polysaccharides secreted by mucosal epithelial cells of the gallbladder, stomach, intestines and
other organs and act as surfactants and protect the mucosal epithelium by preventing enzymatic
self-digestion.20 The bile is concentrated and dehydrated through the actions of the Na+/K+ and
Cl−/HCO3 pumps of gallbladder epithelial cells and/or aquaporins, channels that transport
water.20 These transport channels normally manipulate the composition of gallbladder bile for
production of the final bile product, but in disease states abnormal functioning of bile moisture
absorption mechanisms might be involved in the pathophysiology of gallbladder mucoceles.20
The specific etiology of gallbladder mucocele development in dogs remains unknown,
but a continuous transition from echogenic gallbladder sludge to the stellate and kiwi fruit like
pattern has been proposed.66 Echogenic bile first occupies the gallbladder lumen, then the
formed central gallbladder conglomerate adheres to the gallbladder wall margin (stellate pattern),
and then fine striations increase with a decrease in residual echogenic sludge in the center of the
gallbladder (kiwi fruit like pattern).66 Decreased gallbladder motility (which can be secondary to
geriatric age or steroidal influence) can cause luminal cholestasis and enhanced absorption,
promoting formation of biliary sludge and, in theory, gallbladder mucoceles.1 In an
ultrasonographic study with 43 dogs, 23% had immobile echogenic bile, 30% had an incomplete
stellate pattern, 12% had the typical stellate pattern, 26% had a kiwi like pattern and stellate
combination, 9% had a kiwi like pattern with residual central echogenic bile, and no patients had
a kiwi like pattern.66 The stellate pattern overall was the most common regardless of clinical
signs.66
Progressive expansion of a gallbladder mucocele can cause gallbladder ischemic
necrosis, bile peritonitis, and opportunistic infection.1 In patients with a gallbladder mucocele
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with gallbladder wall rupture, pericholecystic fat will be hyperechoic, the gallbladder may be
surrounded by a rim of anechoic fluid creating a hypoechoic “halo”, and the gallbladder wall
may be hyperemic, thickened, or discuontinuous.41,64,67 A larger volume of peritoneal effusion is
also possible and suggests gallbladder rupture.1 The diagnostic utility of US for detecting
gallbladder rupture in dogs with biliary mucoceles is overall good (especially when combined
with other findings including localized echogenic peritoneal fluid, echogenic reaction in the
gallbladder fossa, and echogenic diffuse peritoneal fluid) but not very specific.1,37 The most
common pattern in dogs with gallbladder rupture was the incomplete stellate pattern in the study
with 43 dogs with gallbladder ruptures due to mucoceles.66 This study also found no significant
correlations between ultrasonographic patterns of gallbladder mucoceles and clinical disease
status or gallbladder rupture.66 However, unfortunately dogs with gallbladder rupture at the time
of surgery are 2.7 times more likely to die than dogs without gallbladder rupture.65 Rarely, a
ruptured gallbladder will release a well-organized mucocele into the peritoneal cavity where it
may cause pain and peritoneal effusion that can be identified on US.1,68,69
Aerobic bacteria have been cultured from bile or gallbladder wall, with a number of
enteric organisms identified including Escherichia coli, Enterobacter spp, Enterococcus spp,
Staphylococcus spp, Micrococcus spp, and Streptococcus spp.1
Approximately 23% of dogs with gallbladder mucoceles do not show clinical signs.41,64,66
An increased incidence of gallbladder mucoceles has been identified in many dog breeds
including Shetland Sheepdogs, American Cocker Spaniels, Chihuahua, Pomeranian, Miniature
Schnauzers, Boston Terriers, and possibly Affenpinschers.43,62,70 Previously identified factors
predisposing to canine patients to gallbladder mucocele formation include middle to geriatric
age, hyperlipidemia/hypercholesterolemia (idiopathic, pancreatitis, nephrotic syndrome, or
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endocrinopathies including hyperadrenocorticism and hypothyroidism), gallbladder dysmotility,
neonicotinoids (a class of insecticides chemically related to nicotine), increased serum leptin, and
cystic mucosal hyperplasia that adheres to mucinous debris and compromises mechanical
gallbladder emptying.1,71,72 Shetland Sheepdogs and Miniature Schnauzers have a breed
predisposition for hyperlipidemia/hypercholesterolemia which may explain their higher
incidence of gallbladder mucocele. Overall, these conditions may alter the composition of bile
and mucin or effect gallbladder motility (with it likely being many mechanisms working
cooperatively concurrently) in gallbladder mucocele formation with both genetic and epigenetic
factors affecting each predisposed breed.19,62
Various genetic and metabolic factors have been identified to affect gallbladder mucocele
formation in dogs. An insertion mutation in the ABCB4 gene has been identified in Shetland
sheepdogs with a recent study showing 14/15 affected dogs had gallbladder mucoceles, but not
20/21 unaffected individuals.48 The ABCB4 gene mutation impairs secretion of a protective
phospholipid across the canalicular membrane that protects the gallbladder epithelium to the
irritant properties of bile.48 A later study did not find the ABCB4 gene mutation to be linked to
gallbladder mucocele formation in this breed.73 This mutation may or may not explain the
predisposition of this breed to gallbladder mucocele formation.48
In another retrospective study of 78 dogs diagnosed with gallbladder mucoceles, the odds
of gallbladder mucocele formation in dogs with hyperadrenocorticism were 29 times that of dogs
without hyperadrenocorticism.49 Also in this population, a weaker positive association was
identified for hypothyroidism as these patients had a threefold increased risk.49
The bloodwork abnormalities in canine patients with gallbladder mucocele are similar to
patients with other biliary diseases or may be normal. A previous study showed 11 of 43 dogs
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(five symptomatic and six asymptomatic dogs) had normal leukocyte counts and normal
concentrations of ALT and total bilirubin.66 The number of leukocytes and serum concentrations
of ALT and total bilirubin were also significantly higher in symptomatic dogs than asymptomatic
dogs, but symptomatic dogs did not all have hyperbilirubinemia.66 Hepatitis with or without
cholangitis has been described in patients with gallbladder mucoceles, and liver biopsies are
recommended during cholecystectomy.47
In order to avert gallbladder mucocele maturation and gallbladder wall ischemic
necrosis, as these patients have a higher chance of death, elective cholecystectomies at early
stages of gallbladder disease can be performed.47 Surgical candidates for the elective procedure
include subclinical gallbladder mucocele or non-gravity dependent biliary sludge with concurrent
gallbladder dysmotility.47
Bile Peritonitis
Bile peritonitis is caused by bile exiting the biliary tract into the peritoneal space causing
marked inflammation in the abdomen. Abdominal pain with peritoneal effusion containing a
disproportionately high bilirubin concentration is consistent with a ruptured biliary tree as with
cholecystitis, choledochitis, neoplasia, gallbladder mucocele, or blunt abdominal trauma.1 These
patients require emergency surgical intervention to resolve the biliary leakage site and
decontaminate the peritoneal space. In febrile animals with suspected biliary disease, early
performance of cytology and cultures of blood, urine, and hepatic or bile aspirates can expedite
identification of involved organisms and appropriate treatment whether surgical or medical.1
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Extrahepatic Biliary Duct Obstruction
Extrahepatic biliary duct obstruction (EHBDO) is a disease process that causes occlusion
of the biliary outflow tract through the bile duct which is most commonly from severe
pancreatitis and obstructive choledocholithiasis. After acute complete obstruction, dilation of the
bile duct and cystic duct are evident within 24 hours.52,74 Distention of intrahepatic bile ducts
occurs within 5 to 7 days after with concurrent hepatomegaly.52,74 Dilated hepatic ducts are
differentiated ultrasonographically from portal and hepatic veins by their irregular branching
patterns, tortuosity, and absence of blood flow on Doppler interrogation.52 Bile duct diameter is
variable and specific numerical diameter cutoffs cannot be used to determine the chronicity of
obstruction.1 However, severe duct dilation develops after 4 to 6 weeks of complete EHBDO.74
Obstruction of hepatic duct(s) within a single liver lobe can be difficult to ultrasound due to the
previously discussed limitations of hepatobiliary US examination. Affected animals are not
hyperbilirubinemic but do have increased liver enzyme activity.1 Once distended by chronic
obstructive pathologies (greater than 6 weeks), intra- and extrahepatic bile ducts may remain
dilated compromising dynamic postprandial assessments and may lead to biliary cirrhosis, portal
hypertension, and acquired portosystemic shunts.1,12,52 If the obstruction resolves within the first
several weeks, periductal fibrosis and bile duct distention may completely resolve.1
During EHBDO, opportunistic bacterial colonization of the biliary tract may occur from
enteric or hematogenously spread agents from the hepato-biliary-enteric bacterial circulation.1
Antimicrobial treatment of biliary sepsis alone is ineffective because of inadequate antibiotic
penetration to the biliary tract and inability to mechanically clear bacterial organisms due to the
obstruction.1 These patients may require surgical biliary decompression. Some patients with
EHBDO are intermittently anorexic while others are polyphagic, consistent with fat maldigestion
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secondary to the absence of duodenal bile acid delivery.1 Extrahepatic biliary duct obstruction
diagnosis can be diagnosed with abdominal US, CT, and/or exploratory laparotomy.
Severe pancreatitis is the most common cause of EHBDO in dogs and causes obstruction
of the bile duct at the level of the duodenal papilla from periductal fibrosis and duct stricture due
to severe inflammation.1 In most dogs with EHBDO secondary to severe acute pancreatitis,
obstruction resolves spontaneously as the pancreatitis resolves, and surgical intervention not
required.1 However, if EHBDO persists beyond 14 days due to pancreatitis, temporary or
permanent decompression (including stent placement) of the biliary tract may be needed.1
Canine patients who do require surgical intervention (as with obstructive choledocholithiasis or
biliary sludge), a duodenotomy, cholecystostomy, and/or choledochotomy may be necessary for
passage of a flexible catheter into the bile duct to verify the site of obstruction and to allow
removal of inspissated biliary sludge or choleliths.1 A previous study of dogs undergoing
extrahepatic biliary surgery in dogs with pancreatitis reported a 50% mortality in dogs and
prolonged hospitalization length.75 Thus, the high complication rates of surgery in concurrent
pancreatic disease in dogs with EHBDO likely reflects the underlying diseases and their effects
on the animal (septic bile peritonitis, higher serum creatinine, prolonged partial thromboplastin
time [PTT], and lower postoperative mean arterial pressure) rather than complications of
surgery.75
A recent retrospective study evaluated 46 dogs with pancreatitis associated bile duct
obstruction (PABDO) to see if presumed markers of disease severity are predictors of survival.76
Thirty-three of 42 (79%) the dogs with PABDO survived. Two of the 4 dogs that underwent
percutaneous or surgical decompression of the gallbladder died. This study found that the
median bile duct dilatation at the time of ultrasonographic diagnosis of PABDO and peak
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bilirubin were not different between survivors and nonsurvivors. The study also concluded dogs
with PABDO often have a prolonged course of illness and improve clinically despite
biochemical evidence (hyperbilirubinemia) of progression of EHBDO.
Choledochal stenting has been extensively used in humans to presurgically decompress
EHBDO, presurgical stabilization, and manage obstructive biliary disease because of malignant
processes.1 Limited publications of dogs with EHBDO managed with choledochal stenting have
been reported.77,78 Stents can be placed during surgical exploration or retrograde endoscopically
via the major duodenal papilla.77,78 Complications of stent placement include stent obstruction
with bile concretions, duct stricture formation due to granulation or fibrous tissue deposition
(promoted by stent mechanical trauma), and intralumenal interference with bile drainage that
promoted cholangitis.1
Biliary Congenital Abnormalities
Congenital abnormalities of the gallbladder are rare and include gallbladder agenesis,
biliary atresia, and bilobed gallbladder. Gallbladder agenesis is defined as the absence of growth
of the gallbladder in utero which is a nonclinical abnormality as the hepatic bile can transit
through the remaining biliary tract normally.1 Biliary atresia is a congenital anomaly where a
portion of the bile duct, cystic duct, or hepatic ducts are malformed and stenotic which leads to
jaundice and progressive hepatopathy in young animals.1 A bilobed gallbladder is an uncommon
incidental finding in cats.
Fibropolycystic Liver Diseases
Fibropolycystic liver diseases have been identified in many species and often involve the
biliary structures and renal tubules.1 Abnormal embryonic ductal plate development at various
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stages forms cystic lesions involving intrahepatic or extrahepatic bile ducts.1 Embryologically,
the ductal plate is comprised of a cylindric tube of cells surrounding portal vein branches.1
Biliary ducts form through remodel and partial involution of the ductal plates.1 Ductal
malformations form as ductal plate components are unevenly remodeled.1 The different types of
malformations are determined by the time and stage of development at which the embryogenesis
and remodeling are disturbed (large ducts versus small ducts, intrahepatic versus extrahepatic).1
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CHAPTER II
STUDY
Study Objectives
This study was performed with the following objectives:
1) To describe the CT appearance of various biliary diseases in dogs presenting for acute
abdominal signs.
2) To compare the accuracy of CT with that of abdominal US in the diagnosis of biliary disease
in dogs presenting with acute abdominal signs.
Hypotheses
The hypotheses were that CT will allow for detection of various biliary diseases in the
dog, including bile duct enlargement, choleliths, and mucocele formation, with similar accuracy
to US, and that US would be superior to CT for investigation of the bile ducts and the diagnosis
of cholecystitis due to the small size of these structures in the dog.
Preliminary Studies
Contrast-enhanced abdominal CT is performed frequently at the Mississippi State
University College of Veterinary Medicine Animal Health Center, and standard protocols have
been developed, which are described in the methods section. In addition, abdominal CT has been
performed on animals presenting for acute abdominal signs. Although abdominal US is more
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commonly performed in canine patients presenting with acute abdominal signs, in cases in which
CT has been performed in these animals, rapid and accurate diagnoses have been made.
Materials and Methods
Study population
This study was a prospective, observational study completed following institutional
IACUC approval. The study population consisted of client-owned dogs presenting to the small
animal care services with acute abdominal signs suspected to be related to the biliary tract whose
diagnostic plan included an abdominal US. Inclusion criteria included patients presenting for any
signs of acute abdominal disease potentially referable to the biliary tract, including vomiting,
lethargy, anorexia, jaundice, abdominal pain, or fever. Exclusion criteria included dogs with a
previous cholecystectomy and patients unable to be sedated. Dogs were enrolled following
informed owner consent. Animals enrolled in the study with signs of acute abdominal pain and
with no evidence of biliary disease on US, cytology, and histopathology served as negative
controls for the comparison of the performance of CT and US. Considering US as the gold
standard for diagnosing biliary disease in dogs, sample size calculations using McNemar’s test of
two dependent groups were performed for detecting biliary disease using available statistical
software (G*Power v 3.1.92, Heinrich Heine, Universität Düsseldorf) and determined a total of
60 dogs were required for adequate statistical power to compare the two modalities. Thirty of
these dogs would be those diagnosed with biliary disease and 30 of these dogs presenting for
acute abdomen with no evidence of biliary disease would serve as negative controls.
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Imaging and measurements
Dogs received an abdominal US examination by a board-certified radiologist or by a
diagnostic imaging resident under supervision of a board-certified radiologist either immediately
prior to or following the CT examination, using a GE LOGIQ S8 ultrasound machine (General
Electric, Boston, MA) with a C3-10-D Broad Spectrum microconvex transducer (6-10 MHz) or a
11L-D linear transducer (9-12 MHz), depending on body size (General Electric, Boston, MA).
Briefly, the dogs were placed in dorsal or in left lateral recumbency, depending on body size.
The hair was locally clipped, and coupling gel was applied to provide adequate probe contact.
An US was performed according to the preferences of the sonographer and included both still
images and cine clips of the liver, gallbladder, bile duct, and pancreas.
Dogs were sedated as needed, using protocols chosen by the attending clinicians on each
case. The sedation protocol was recorded. The animals then underwent a dual-phase abdominal
CT examination using a Toshiba Aquilion 16-slice multi-detector scanner (Toshiba Corp,
Toshiba American Medical Systems, INC., Tustin, CA). Dogs were positioned in ventral
recumbency, and the field of view included the cranial aspect of the diaphragm cranially and the
acetabula caudally. The following protocols were used: 16 x 0.5 or 16 x 1.5 mm collimation,
100-120 kVp, 80-200 mAs, a helical pitch of 1.5, and a field of view large enough to encompass
the abdomen. All protocols were based on patient size and determined by the principal
investigators or a board-certified radiologist overseeing radiology residents, interns, and certified
technicians. A precontrast series was acquired. Immediately following this acquisition, all
animals were administered a bolus of ioversol (Optiray 320, Guerbet, Princeton, JN) or iohexol
(Omnipaque 240, GE Healthcare, Marlborough, MA) at 704 mg/kg body weight for ioversol and
527 mg/kg body weight for iohexol via an intravenous catheter followed by a saline flush, some
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with the assistance of a power injector. Early hepatic (10-30 seconds) and late venous (90-120
seconds) post-contrast series were then acquired. All images were acquired using a soft tissue
algorithm with variable slice thickness ranging from 1 mm to 3 mm, based on patient size.
Transverse, sagittal, and dorsal reconstructions were created based on volume acquisitions in all
phases.
Following imaging, all CT and US images and clips were sent to a picture archiving and
communication system (PACS) and displayed using a digital imaging and communications in
medicine viewer (eUnity, Client Outlook Inc, Ontario, Canada). The radiologist and a radiology
resident were blinded to the results of the US and reviewed randomized, anonymized CT images
and US images and cine clips. Specifically, the evaluators recorded the following on CT:
gallbladder wall thickness, HU of the bile, presence or absence of hyperattenuating material
within the gallbladder lumen (and whether or not it is gravity dependent), ability to identify the
bile duct and intrahepatic bile ducts, and, if applicable, size of the bile duct and intrahepatic bile
ducts. The following US findings were recorded: gallbladder wall thickness, presence or
absence of hyperechoic material within the gallbladder lumen, ability to identify the bile duct
and intrahepatic bile ducts, and, if applicable, size of the bile duct and intrahepatic bile ducts.
The CT and US appearance of the liver and pancreas and a final CT and US diagnosis were also
recorded. The observers’ measurements were averaged. Any discrepancies were discussed until a
consensus was made.
Patients were considered to be positive for biliary pathology on CT or US for any of the
following criteria: thickened gallbladder wall, dilated bile duct or intrahepatic bile ducts,
cholelithiasis, and findings previously described to be consistent with a gallbladder mucocele.
The presence of gallbladder sludge on US was not considered as positive for biliary pathology.
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While it has been linked to decreased gallbladder emptying, there has not been a strong
correlation to clinical signs as an isolated finding in dogs. Final clinical diagnoses were positive
for biliary pathology by pathology identified by US, cytology, and/or histopathology. Mineral
attenuating structures identified on CT were also considered to be positive for pathology as it has
been previously acknowledged to be more sensitive that US in the detection of mineral
attenuating structures.23 The final clinical diagnoses were used to compare the positive or
negative diagnoses of CT and US.
Statistical Methods
Agreement between each modality and final clinical diagnosis for the outcomes of
gallbladder wall mass, gallbladder mucocele, gallbladder wall edema, cholelith, cholangitis,
hepatitis, pancreatitis, pancreatic edema, and cystic mucosal hyperplasia and agreement between
the two modalities for the previously listed outcomes as well as wall thickness, bile HU, bile duct
identification, bile duct size, hepatic duct identification, hepatic size, liver, and pancreas were
assessed by intraclass correlation coefficients (ICC)79 using PROC MIXED in SAS for Windows
v. 9.4 (SAS Institute, Inc., Cary, NC). Models for each pairwise comparison were fitted with the
outcome as the dependent variable and method of diagnosis (US vs CT, US vs final clinical
diagnosis, or CT vs final clinical diagnosis) as the fixed effect with dog identity included as a
random effect80. The association between true pathology diagnosis and diagnosis by each
modality (US or CT) were assessed by separate logistic regression models using PROC
LOGISTIC in SAS for Windows v9.4 with true pathology as the dependent variable. Where
necessitated by scarcity of data, analysis of penalized maximum likelihood estimates using the
firth option was used. An alpha level of 0.05 was selected a priori. Although no standard values
for acceptable agreement using ICC have been established,81 suggested that ICC values less than
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0.5, values between 0.5 and 0.75, values between 0.75 and 0.9, and values greater than 0.9
indicated poor, moderate, good, and excellent agreement. All statistical analyses were performed
by a board-certified epidemiologist with extensive experience in statistical analyses.
Study results
Study population results
The age of the population ranged from 2 to 20 years old with a mean of 9.1 years old and
median of 10 years old. The weight of the population ranged from 2.6 to 50 kg with a mean of
12.4 kg and median of 7.2 kg. The breeds of the included dogs were as follows: 5 Yorkshire
terriers, 4 mixed breed dogs, 3 Labrador retrievers, 2 chihuahuas, 2 miniature poodles, 2
miniature schnauzers, 2 standard poodles, and 1 of each the following American pit bull, beagle,
boxer, Cairn terrier, Chinese crested, dachshund, English bulldog, Jack Russell terrier, maltepoo,
Maltese, rat terrier, Shetland sheepdog, Shih tzu, Welsh corgi, and West Highland terrier.
Anorexia was the most common clinical sign (24 of 35 patients). Vomiting (21 of 35
patients) and lethargy (20 of 35 patients) were the next most common clinical signs. The least
common clinical signs were jaundice (4 of 35 patients), abdominal pain (2 of 35 patients), and
fever (1 of 35 patients). Twenty-six of the 35 patients with clinical signs had at least 2 or more
clinical signs.
Imaging results
Thirty-five patients were enrolled in the study with 28 having biliary pathology and seven
having no evidence of biliary disease serving as controls. The final clinical diagnoses of patients
with biliary pathology included cholelithiasis (n=7), gallbladder mucoceles (n=6),
cholangiohepatitis/cholangitis (n=6), extrahepatic biliary obstruction (n=5), gallbladder wall
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edema (n=2), gallbladder wall mass (n=1, malignant carcinoid), and cystic mucosal hyperplasia
(n=1). The gallbladder mucoceles also had cholangiohepatitis with many also having cystic
mucosal hyperplasia. One of the gallbladder mucoceles had confirmed gallbladder wall rupture
with one other case having a possible ruptured at surgery. The five extrahepatic biliary duct
obstructions were due to pancreatitis (n=2) and choledocholithiasis (n=3). Three cases (bacterial
cholangitis, cholecystitis, and cystic mucosal hyperplasia) also had mineralized gallbladder
sludge and/or pinpoint choleliths on the CT studies. The final diagnoses in the control patients
included pancreatitis (n=2), neoplasia involving the liver (n=2, metastatic oral melanoma and
lymphoma), hepatitis (n=1), acute hemorrhagic gastroenteritis (n=1), and presumed Fanconi
syndrome (n=1). The summary of the patients’ signalment, final positive or negative diagnosis
for biliary pathology, and described final clinical diagnosis and cytology and histopathology
results are summarized in Table 1.
Table 2.1

Summary of the patient’s signalment (age, sex, breed, weight), true pathology
diagnosis of positive or negative for biliary pathology, and described final clinical
diagnosis with cytology and histopathology diagnoses when available. For sex,
FI=female intact, FS = female spayed, MI=male intact, and MN=male neutered.

Age
(years)

Sex

10

FS

8

FS

4

MN

9

FS

9

FS

Breed
Miniature
Poodle
Miniature
Schnauzer
American
Pit Bull
Shetland
Sheepdog
Miniature
Schnauzer

20
12

MN
FS

Mixed bree
dog
Rat Terrier

Weight
(kg)

True
Pathology

10.6

Positive

Described Final Clinical Diagnosis and Cytology/Histopathology
Results
Gallbladder mucocele confirmed by surgery and histopathology.
Liver histopathology - cholangiohepatitis

8.6

Positive

Copper storage disease on liver biopsy. Cholelith

33.5

Positive

6.1

Positive

6

Positive

6.3
8.8

Positive
Positive

Presumed anaphylaxis
Gallbladder mucocele on surgery and histopathology. Liver
histopathology - chronic active hepatitis
Pancreatitis. Cholangiohepatitis. Probable delayed plasma
transfusion reaction
Gallbladder mucocele confirmed by surgery and histopathology.
Liver histopathology - cholestatic hepatic portal fibrosis and mild
suppurative cholangiohepatitis
Gallbladder mucocele confirmed by surgery and histopathology.
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Table 2.1 (continued)
4

FS

14

MN

10

FS

10

MN

10

FS

Yorkshire
Terrier
Standard
Poodle
English
Bulldog
Miniature
Poodle
Welsh
Corgi

12

FS

6

7.2

Negative

Pancreatitis

20

Negative

Oral melanoma metastasis to liver

17.1

Positive

Gallbladder mass malignant carcionoid on histopathology

4.2

Positive

Pancreatitis causing extrahepatic biliary duct obstruction

17.4

Negative

Chinese
Crested

4

Positive

FS

Maltese

5.7

Positive

8
10

MN
MI

Cairn
Terrier
Chihuahua

8.5
3.4

Positive
Positive

12

FS

6.7

Positive

5

FI

44.5

Positive

9

FS

2.6

Positive

9
4

FS
FS

Beagle
Labrador
Retriever
Mixed
breed dog
Mixed
breed dog
Shih Tzu

Histopathology - stage IV multicentric T cell lymphoma of liver
Histopathology - severe cholangiohepatitis (lymphoplasmacytic
and suppurative) and severe acute hepatocellular necrosis.
Concern for toxin then severe chronic pancreatitis
Pancreatitis. Cholelithiasis. Liver cytology - cholestasis and
suspect mild mixed inflammation with neutrophilic predominance
Liver histopathology - moderate to severe chronic
cholangiohepatitis that is likely due to an ascending biliary tree
infection with chronic cholestasis
Cholelith. Pancreatitis. Liver cytology - cholestasis
Ruptured gallbladder mucocele at surgery. Necropsy concluded
systemic inflammatory response syndrome secondary to
necrosuppurative cholecystitis
Cholelith. Chronic hepatitis. Liver cytology - significant
cholestasis and mild to moderate hepatocellular vacuolization

18.2
5.8

Positive
Negative

7

FI

Boxer

23.8

Negative

10

MN

23.9

Positive

3

FI

5.6

Negative

11

FS

23.3

Positive

10

FS

Labrador
Retriever
Yorkshire
Terrier

7.2

Positive

9

MN

Yorkshire
Terrier

4.9

Positive

12

FS

3.6

Positive

4

FS

Yorkshire
Terrier
Yorkshire
Terrier

3.4

Negative

11

FS

Maltepoo

4.7

Positive

Standard
Poodle
Jack
Russell
Terrier

Cholecystolithiasis. Obstructive choledocholithiasis.
Cholecystolith. Gastritis. Hyperadrenocorticism. Liver cytology mild lipid accumulation
Presumptive Fanconi Syndrome
Liver histopathology - vacuolar hepatopathy (steroid hepatopathy),
diffuse, chronic, severe with mild cholestasis. Small intestines
histopathology - proliferative enteritis.
Bacterial cholangitis. Mineralized gallbladder sludge and pinpoint
choleliths. Bile cytology - significant bactibilia with E. coli
growth. Liver cytology - no significant hepatocellular atypia

Gastroenteritis. Possible pancreatitis
Severe pancreatitis with secondary extrahepatic biliary
obstruction. Bile cytology - normal with no growth on culture.
Liver cytology - cholestasis
Pancreatitis. Gastritis. Colitis. Mineralized gallbladder
sludge/pinpoint cholecystolithiasis
Cholecystitis. Cholelithiasis. Pancreatitis. Normal bile cytology
with no growth on culture. Liver cytology - compatible with
lymphoma and evidence of cholestasis.
Obstruction secondary to choledocholith and cholecystolithiasis.
Surgery confirmed. Gallbladder culture - moderate growth of
possible hemolytic Escherichia coli. Pancreatitis
Acute hemorrhagic gastroenteritis
Obstruction secondary to choledocholith and cholecystolithiasis.
Cholecystitis. Liver cytology - probable mild mixed inflammation
and modest amounts of cholestasis. Bile culture - heavy growth of
Enterobacter cloacae. Bile cytology - significant bactibilia
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Table 2.1 (continued)

14

MN

Chihuahua

5.6

Positive

2

FS

Mixed bree
dog

15.2

Positive

Cystic mucosal hyperplasia, mineralized gallbladder
sludge/pinpoint cholecystoliths. Right external iliac artery
thrombus. Bile cytology: normal. Bile culture: Growth of Bacillus
sp
Protein-losing enteropathy. Cholangitis vs gallbladder wall edema.
Pancreatic edema. Stomach histopathology - eosinophilic,
lymphoplasmacytic gastritis with fibrosis, mild, chronic-active.
Duodenum histopathology - eosinophilic, lymphoplasmacytic
duodenitis with lacteal dilation, mild to moderate, chronic-active

5.6

Positive

Mineralized gallbladder sludge or pinpoint choleliths. Concern for
primary liver pathology. Liver cytology - minimal evidence of
active chronic hemorrhage, mild hepatic lipidosis, probable mild
mixed inflammation

50

Positive

Severe acute pancreatitis. Focal choledochitis

10.3

Positive

Gallbladder mucocele with possible rupture. Pancreatitis

12

FS

5

MI

12

MN

Dachshund
Labrador
Retriever
West
Highland
Terrier

Statistical evaluation was performed to evaluate agreements between both modalities (US
and CT) compared to the final clinical diagnoses (Table 2.2).
Table 2.2

Summary of positive and negative final diagnoses determined on true pathology,
ultrasound, and computed tomography.

Total positive
Total negative

US
22
13

CT
29
6

TRUE
28
7

There was a significant association between the final US positive or negative diagnosis
for biliary pathology and the final clinical diagnosis (p=0.0116) via analysis of paralyzed
maximum likelihood estimates and a chi-square (Figure 2.1). The odds of the final clinical
diagnosis being positive when the US diagnosis was positive is 51.9 times greater than when the
US diagnosis was negative. This was a 95% Wald confidence limits of 2.421->999.999. The
overall calculated accuracy of the ultrasonographic final diagnoses compared to the true
pathology was 82.9% (29/35 of patients). There were six false negative cases due to
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cholelithiasis which were identified on CT. When the six false negative diagnoses for
cholelithiasis were removed, US agreed with the remaining 29 final clinical diagnoses with other
biliary pathologies (discussed more below).

Figure 2.1

Statistical evaluation of the final positive or negative ultrasonographic diagnosis
compared to the true diagnosis for biliary pathology in this group of canine
patients.

There was a significant association between the final CT positive and negative diagnosis
and the final clinical diagnosis for biliary pathology (p=0.0022) via analysis of paralyzed
maximum likelihood estimates and a chi-square (Figure 2.2). The odds of the final clinical
diagnosis being positive when final CT diagnosis was positive is 247.0 times greater than when
CT final diagnosis was negative. The overall calculated accuracy of the CT final diagnosis
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compared to the true pathology was 97.1% (34/35 of patients). One false positive case had
identified a dilated bile duct on the CT study (bile duct measured 5 mm in diameter) while the
biliary tract was normal on US.

Figure 2.2

Statistical evaluation of the final positive or negative computed tomographic
diagnosis compared to the true diagnosis for biliary pathology in this group of
canine patients.

Both US and CT successfully identified the one gallbladder wall mass (malignant
carcinoid) with 100% agreement in all cases (Figure 2.3).
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Figure 2.3

Canine malignant gallbladder carcinoid on CT and US. Left image: Strong
homogenous arterial contrast enhancing gallbladder wall mass on CT (transverse
soft tissue window). Right image: Same gallbladder wall mass on US (longitudinal
view) which displayed a large amount of blood flow on color Doppler
interrogation.

Ultrasound and CT performed equally to identify all of the gallbladder mucoceles as
there were no discordant pairs and the ICC equaled 1.0000 (Figure 2.4). Both US and CT
successfully identified the six gallbladder mucoceles with 100% agreement in all cases. All
gallbladders had similar imaging appearances as previously described.
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Figure 2.4

Canine gallbladder mucocele on US and CT. Left image: Classic appearance of a
canine gallbladder mucocele with central stellate hyperechoic intraluminal
material, gallbladder dilation, thickened and hypoechoic gallbladder wall, small
volume surrounding peritoneal free fluid, and hyperechoic mesentery consistent
with peritonitis. Right image: Same gallbladder mucocele on CT (noncontrast
enhanced transverse soft tissue window) with severe gallbladder dilation and
central hyperattenuating material.

There was no significant difference with moderate agreement between the proportions
that were positive and negative on US and CT in the identification of the gallbladder wall edema
as the McNemar’s test P-value was 0.2500 and ICC was 0.55556. Both US and CT successfully
identified the two gallbladder wall edema cases. Additionally, CT had three false positives for
gallbladder wall edema. There was no significant difference with moderate agreement between
the proportions that were positive and negative on CT identifying gallbladder wall edema as the
McNemar’s test P-value was 0.2500 and ICC was 0.66340.
There was no significant difference with good agreement between the proportions that
were positive and negative on US and CT in the identification of the cholangitis as the
McNemar’s test P-value was 0.2500 and ICC was 0.82796. Both US and CT successfully
identified the 21 cholangitis cases with US agreeing with all of the final clinical diagnoses of the
65

cases with and without cholangitis. Many of these cases had concurrent pathologies such as a
gallbladder mucocele or cholelithiasis. There was no significant difference with good agreement
between the proportions that were positive and negative on CT identifying cholangitis as the
McNemar’s test P-value was 0.2500 and ICC was 0.84368.
There was statistical significance with poor agreement in the identification of
cholelithiasis between US and CT as the McNemar’s test P-value was 0.0039 and ICC was
0.47297. Ultrasound only successfully identified five of the 13 cases with cholelithiasis resulting
in eight false negatives (Figure 2.5). This was statistically significant as the McNemar’s test Pvalue was 0.0078 and ICC was 0.70431. Computed tomography identified all the cases of
cholelithiasis with one additional false positive (a case with a confirmed gallbladder mucocele).
There was no significant difference with excellent agreement between the proportions that were
positive and negative on CT identifying cholecystolithiasis as the McNemar’s test P-value was
1.0000 and ICC was 0.96129. This showed CT agreed with the cholelithiasis final diagnosis
more than US.
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Figure 2.5

Canine cholelithiasis on CT and US. Left image: Mineral attenuating structure in
the gravity dependent portion of the gallbladder on CT consistent with a
cholecystolith (contrast enhanced transverse soft tissue window image). Right
image: Same structure on US with color Doppler interrogation in the sagittal plane.
This structure is hyperechoic and has a similar shape to the structure on CT but
does not display distal acoustic shadowing or twinkle artifact so was dismissed as
inspissated gallbladder sludge.

There was no significant difference with poor agreement between the proportions that
were positive and negative on US and CT in the identification of hepatitis as the McNemar’s test
P-value was 0.5488 and ICC was 0.21667. There was no significant difference with poor
agreement between the proportions that were positive and negative on US and CT in the
classification of the liver as being normal or abnormal as the McNemar’s test P-value was 0.2266
and ICC was 0.39189. Not all cases had liver cytologic and/or histopathologic.
Ultrasound identified eight of the 16 confirmed hepatitis cases with three false positives
and eight false negatives. There were 16 cases determined to be normal on US that were also
normal on the final hepatic diagnosis. There was no significant difference with moderate
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agreement between the proportions that were positive and negative on US identifying hepatitis as
the McNemar’s test P-value was 0.2266 and ICC was 0.59151.
Computed tomography identified five of the 16 confirmed hepatitis cases with three false
positives and 11 false negatives. There were 16 cases determined to be normal on CT that were
also normal on the final hepatic diagnosis. There was no significant difference with poor
agreement between the proportions that were positive and negative on CT identifying hepatitis as
the McNemar’s test P-value was 0.0574 and ICC was 0.48794.
There was no significant difference with poor agreement between the proportions that
were positive and negative on US and CT in the identification of pancreatitis as the McNemar’s
test P-value was 0.2891 and ICC was 0.46341. No pancreatic cytologic and/or or
histopathologic diagnoses were obtained, and these were the clinical final diagnoses due to
ultrasonographic appearance, blood work abnormalities, and clinical exam findings. There was
no significant difference with poor agreement between the proportions that were positive and
negative on US and CT in the classification of the pancreas as being normal or abnormal as the
McNemar’s test P-value was 0.1797 and ICC was 0.45076.
Ultrasound identified seven of the 15 confirmed pancreatitis cases with one false positive
and eight false negatives. There were 19 cases determined to be normal on US that were also
normal on the final pancreatic diagnosis. There was a significant difference with moderate
agreement between the proportions that were positive and negative on US identifying
pancreatitis as the McNemar’s test P-value was 0.0391 and ICC was 0.67773.
Computed tomography identified 11 of the 15 confirmed pancreatitis cases with one false
positive and four false negatives. There were 19 cases determined to be normal on CT that were
also normal on the final pancreatitis diagnosis. There was no significant difference with good
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agreement between the proportions that were positive and negative on CT identifying
pancreatitis as the McNemar’s test P-value was 0.3750 and ICC was 0.81291.
There was no significant difference with moderate agreement between the proportions
that were positive and negative on US and CT in the identification of pancreatic edema as the
McNemar’s test P-value was 0.5000 and ICC was 0.65263. Ultrasound identified two of the
three confirmed pancreatic edema cases with no false positives and one false negative. There
was no significant difference with good agreement between the proportions that were positive
and negative on US identifying pancreatic edema as the McNemar’s test P-value was 1.0000 and
ICC was 0.86996.
Computed tomography identified three of the three confirmed pancreatic edema cases
with one false positive and no false negatives. There was no significant difference with good
agreement between the proportions that were positive and negative on CT identifying pancreatic
edema as the McNemar’s test P-value was 1.0000 and ICC was 0.89385.
There was no significant difference with poor agreement between the proportions that
were positive and negative on US and CT in the identification of cystic mucosal hyperplasia as
the McNemar’s test P-value was 0.0625 and ICC was 0.42748. Subjectively cystic mucosal
hyperplasia was easier to identify on US as it was easier to differentiate between the intraluminal
bile and the cystic wall thickening where on CT the wall thickening and the bile were similar in
attenuating and confluent (Figures 2.6 and 2.7). Adjacent material of a different attenuation such
as mineralized intraluminal material was necessary to identify the cystic mucosal hyperplasia on
CT to outline the undulating and thickened mucosa (Figure 2.7). The periphery of the
gallbladder wall did enhance as a thin rim.
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Figure 2.6

Cystic mucosal hypertrophy identified on US (sagittal view). There is multifocal
hypoechoic thickening of the gallbladder wall.

Figure 2.7

Canine patient with confirmed cystic mucosal hyperplasia and cholecystolithiasis
on CT (venous contrast enhanced soft tissue window in a sagittal reconstruction).
The mineralized intraluminal material outlines the undulating gallbladder mucosal
margin which is consistent with cystic mucosal hypertrophy.
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There was moderate agreement between US and CT in the measurement of gallbladder
wall thickness as the convergence criteria was met and the ICC was 0.53775. Eighteen cases had
a gallbladder wall that was thickened (>2 mm) on at least one of the modalities (summarized in
Table 3). Eleven of these cases measured thickened on both CT and US, and seven cases
measured thickened on only one of the modalities. The box and whiskers plot (Figure 2.8)
shows the difference in millimeters (mm) between the measured thickness of the gallbladder wall
on US and CT. The average difference was 1.46 mm. The median difference was 0.7 mm. The
minimum difference was 0 mm, and the maximum difference was 8.7 mm.

Table 2.3

Gallbladder (GB) wall thickness measured on ultrasound (US) and computed
tomography (CT) with the difference in millimeters (mm). Agreement was
determined as yes (Y) or no (N) if both modalities agreed that the gallbladder wall
was enlarged (greater than 2 mm in thickness). N/A = not applicable.

US GB Wall Thickness
(mm)
3.6
0.7
12.4
11.1
2.7
8.9
4.5
1.5
1
1.2
1.6
1.9
3.9
1.3
2.8
1.6
6.7
1.8

CT GB Wall Thickness (mm)
2.2
2
11
2.4
1.7
2
9.2
2
1.6
1.5
1.2
2.1
2.1
1.5
4.5
1.2
2.9
1.8
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Difference (mm)
1.4
1.3
1.4
8.7
1
6.9
4.7
0.5
0.6
0.3
0.4
0.2
1.8
0.2
1.7
0.4
3.8
0

Agreed if
enlarged
Y
N/A
Y
Y
N
N
Y
N/A
N/A
N/A
N/A
N
Y
N/A
Y
N/A
Y
N/A

Table 2.3 (continued)
1.2
0.9
1.2
0.9
3.4
1.2
1.3
0.7
3.5
1.2
0.8
2.3
8.4
3.1
1.5
1.1
2.7

1.9
1.5
1.1
1.4
3.1
2.1
1.9
1.5
3.5
2.4
1.5
1.6
3
2.4
1.4
2.8
1.9

0.7
0.6
0.1
0.5
0.3
0.9
0.6
0.8
0
1.2
0.7
0.7
5.4
0.7
0.1
1.7
0.8

Average difference:
Median difference:
Minimum difference:
Maximum difference:

1.46
0.7
0
8.7
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N/A
N/A
N/A
N/A
Y
N/A
N/A
N/A
Y
N
N/A
N
Y
Y
N/A
N
N

Figure 2.8

Box and whiskers plot of the difference in millimeters (mm) between the measured
thickness of the gallbladder wall on US and CT.

The bile duct was identified in all CT studies. The bile duct was identified in 18 of 35
patients on US. Nine of these 18 bile ducts that were identified on US were normal in size. The
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bile ducts that were unidentified on US and were identified on CT (17 patients), only four of
these bile ducts were dilated on the CT studies, ranging from 3.5-9.9 mm in diameter. Sixteen
cases had a bile duct that was enlarged (>3 mm) on at least one of the modalities (Table 2.4).
Nine of these cases measured thickened on both CT and US, and seven cases measured thickened
on only CT. The box and whiskers plot (Figure 2.9) shows the difference in millimeters (mm)
between the measured bile duct thickness on US and CT of the bile ducts that were measured on
both modalities. The average difference was 1.88 mm. The median difference was 0.7 mm. The
minimum difference was 0 mm, and the maximum difference was 13.6 mm. There was poor
agreement between US and CT in the measurement of bile duct size when it was identified as the
convergence criteria was met and the ICC was 0.43153.
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Table 2.4

Bile duct (BD) thickness measured on ultrasound (US) and computed tomography
(CT) with the difference in millimeters (mm). Agreement was determined as yes
(Y) or no (N) if both modalities agreed that the bile duct was enlarged (greater than
3 mm in thickness). N/A = not applicable.

US BD Thickness (mm)
Not seen
2.2
Not seen
7.3
1.2
6.3
2.1
Not seen
1.1
6.6
6.9
Not seen
Not seen
Not seen
Not seen
Not seen
6.7
Not seen
4.3
Not seen
2.2
Not seen
Not seen
Not seen
2.4
1.7
1.3
8.3
Not seen
4.2
2.5
Not seen
Not seen
6.6
Not seen

CT BD Thickness (mm)
2.8
2.6
2.1
9
3.4
5.6
2.8
2.1
3.7
12.1
5.8
2.9
1.8
4.7
3.5
1.7
6.8
2.9
6.5
1.7
1.7
1.8
9.9
1.7
16
1.7
1.7
8.3
1.9
5.7
2
1.8
2.3
6.7
4.5
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Difference (mm)
N/A
0.4
N/A
1.7
2.2
0.7
0.7
N/A
2.6
5.5
1.1
N/A
N/A
N/A
N/A
N/A
0.1
N/A
2.2
N/A
0.5
N/A
N/A
N/A
13.6
0
0.4
0
N/A
1.5
0.5
N/A
N/A
0.1
N/A

Agreed if enlarged
N/A
N/A
N/A
Y
N
Y
N/A
N/A
N
Y
Y
N/A
N/A
N
N
N/A
Y
N/A
Y
N/A
N/A
N/A
N
N/A
N
N/A
N/A
Y
N/A
Y
N/A
N/A
N/A
Y
N

Table 2.3 (continued)
Average difference:
Median difference:
Minimum difference:
Maximum difference:

1.88
0.7
0
13.6
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Figure 2.9

Box and whiskers plot of the difference in millimeters (mm) between the measured
thickness of the bile duct on US and CT. These are the calculated differences
between the bile ducts that were identified on both modalities.
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The hepatic bile ducts were identified on five of the US studies. The hepatic bile ducts
were identified on 20 of the CT studies. There was no agreement between US and CT in the
measurement of hepatic bile duct size when it was identified as the convergence criteria was met
and the ICC was 0.
Hypoattenuating bile was identified in 11 cases with a range of 10-29 HU. The final
clinical diagnoses of these cases included cholangitis (n=5), extrahepatic biliary duct obstruction
(n=4), gallbladder wall mass (n=1, carcinoid), and a case with cholelithiasis, pancreatitis,
cholestasis.
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CHAPTER III
DISCUSSION
Discussion
This study aimed to compare the performance of contrast-enhanced dual phase abdominal
CT to abdominal US when diagnosing biliary disease in dogs presenting with acute abdominal
signs.
The data supported the first hypothesis that CT would allow for detection of various
canine biliary diseases with similar accuracy to US. The data did not support the second
hypothesis that US would be superior to CT for investigation of the bile ducts and the diagnosis
of cholecystitis due to the small size of these structures in the dog. The study found that CT
identified all bile ducts while US did not. There also was no agreement of the hepatic bile duct
identification between the 2 modalities which does not support US having better identification of
these structures.
There is a significant association between the final US and CT positive or negative
diagnosis for biliary pathology and the final clinical diagnosis via analysis of paralyzed
maximum likelihood estimates and a chi-square (US had P-value= 0.0116 and CT had P-value=
0.0022). Computed tomography had a higher odds ratio of the final clinical diagnosis being
positive when the CT diagnosis is positive (247.0 times greater than when the CT diagnosis is
negative) versus US which was 51.9 times greater than when the US diagnosis is negative. The
95% Wald confidence limits for each modality were 2.421->999.999 (towards infinity). This is
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an unusual value for the upper limit of the confidence interval (trending towards infinity) and is
due to the low numbers of negative results (n=7). This suggests there is not a good estimate of
the odds ratio but since there is a significant association, and the odds ratio is greater than 1.
Overall, there was no statistical difference between US and CT to identify the gallbladder
mucoceles, gallbladder wall mass, gallbladder wall edema, cholangitis, pancreatic edema, and
cystic mucosal hyperplasia.
Subjectively cystic mucosal hyperplasia was easier to identify on US as it was easier to
differentiate between the intraluminal bile and the cystic wall thickening where CT it appeared as
homogenous with the intraluminal bile. Adjacent material with a different attenuation (such as
mineral) was necessary to identify the cystic mucosal hyperplasia on CT as the wall did not
diffusely contrast enhanced because of the wall thickening is more fluid attenuating.
Cholelithiasis was the most common biliary pathology in this patient group which is
similar to previous publications.40 Cholelithiasis was the only pathology with statistical
difference between US and CT to identify. This is not an unexpected finding as CT is known to
be better at identifying mineral structures, especially small ones.23 There may also be a bias
towards CT having better identification of choleliths since it was used as the gold standard in this
study to identify mineral structures. Abdominal radiographs were also obtained for each study
prior to ultrasound. Of the six false negative US cases for cholelithiasis identification, only one
of the cases had a faintly mineralized structure within the region of the gallbladder on the
corresponding radiographs. Radiography could have been used as a confirmatory test, but due to
the small structure size and/or amorphous mineralized gallbladder sludge, majority of these
structures did not cause enough change in the x-ray beam attenuation to be identified.
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Possible causes for decreased US identification of cholelithiasis include small structure
size, decreased viewability from overlying gas or mineral structures, and lack of US artifacts
suggesting mineral composition such as distal acoustic shadowing and twinkle artifact.
Additional consideration for the decreased ability of US to identify small choleliths is the use of
spatial compounding. Spatial compounding is an ultrasonographic technique and setting that
obtains ultrasonographic information from several different angles of interrogation and combines
them to produce a single image. This reduces speckle artifact and distal acoustic shadowing
which improves interrogation of structures deep to distally shadowing structures and betters
delineated margins.83 The compromise to reducing distal acoustic shadowing with spatial
compounding is smaller mineral structures may not display enough shadowing to be identified as
mineral leading to false negative cases and decreased sensitivity. This was identified in a canine
study comparing conventional ultrasonography to spatial compound imaging evaluating canine
nephrolithiasis as distal acoustic shadowing artifacts were present in 43% of spatial compound
imaging mode and 86% of conventional imaging mode.84 This may be a focus of interest for
future projects where spatial compounding is turned off during examination of the biliary tract
for a brief period to evaluate for these small structures.
There was moderate agreement between US and CT for gallbladder wall thickness. Over
half of the cases had a difference between the measurements <1 mm. The cases with >1 mm
difference would be clinically significant as normal is <2 mm in thickness. A possible cause for
the >1 mm difference between modalities includes CT being unable to differentiate between
cystic mucosal hyperplasia and intraluminal fluid. Another possible cause may be changes in
pathology between studies. Most patients received both studies within 1 hour of each other, but a
couple of patients were dehydrated upon presentation, and it was deemed not safe for the patients
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to receive intravenous contrast. Patients who are dehydrated are at a high risk of acute kidney
failure after intravenous iodinated contrast administration. These patients received intravenous
fluid therapy overnight and the contrast enhanced CT study was performed the following
morning. All studies were performed within 24 hours. It is possible these there was a change in
pathology (progression or improvement) over this time period within these couple of patients. If
the underlying etiology was due to inflammation (such as pancreatitis or cholangiohepatitis)
supportive care may have allowed the biliary pathology to improve due to the decreased
inflammation. In cases where extrahepatic biliary outflow obstruction was present, pathology
may have progressed as the obstruction persisted. Also, intravenous fluid therapy may have led
to a positive fluid balance leading to gallbladder wall edema from increased hydrostatic pressure
or cholecystitis. However, due to the few cases this occurred in, it likely did not affect the overall
average differences. A third possible cause is volume averaging which may artificially increase
or decrease the measurement of the gallbladder wall thickness. Volume averaging is an artifact
that occurs when tissues of widely different attenuation (such as mineral and soft tissue) are
included in the same computed tomographic voxel producing a beam attenuation proportional to
the average value of the tissues. Volume averaging has been shown to cause more severe
deviations in measurements of items or tissues with high contrast differences such as bone, air,
and soft tissue.85 Further, measurements are most accurate on CT in the axial plane as volume
averaging causes progressive inaccuracy of measurements in sagittal and dorsal
reconstructions.85 Volume averaging would likely increase the gallbladder wall thickness which
was adjacent to the surrounding hepatic parenchyma as it would cause an increase in the
attenuation of the affected voxels leading to a thicker wall appearance as the attenuations of each
tissue are similar. The opposite would likely occur for the gallbladder wall thickness when
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surrounded by peritoneal fat as there is a high contrast difference between the soft tissue and fat
attenuation which would lead to artificially small gallbladder wall. Similar findings have been
found in other regions of the body where there is high contrast difference between adjacent tissue
types such as loss of visualization of osseous nasal turbinates due to surrounding fluid (high
contrast difference of the thin osseous nasal turbinates and surrounding fluid) and appearance of
tympanic bulla wall thickening with surrounding fluid (high contrast difference of the relatively
thicker tympanic bulla wall and fluid).86,87 This has also been confirmed with aluminum
phantoms surrounded by water and gas where the phantom thickness was artificially enlarged
when surrounded by fluid than when surrounded by gas.87 This phenomenon is worsened with
soft tissue algorithms and reconstructions.87
There was also poor agreement between US and CT for bile duct thickness. Computed
tomography identified the bile ducts in all studies. The bile ducts not identified on US were both
normal in size and enlarged. There are numerous potential causes for the difference in
measurement between the two modalities. Computed tomography has better evaluation of the
porta hepatis due to lack of overlying structures as compared to US which may allow for a more
thorough evaluation of the bile duct along its course. There are additional US artifacts which can
also limit the ability for US to evaluate the bile duct which include the distal acoustic shadowing
from overlying gastrointestinal gas or mineral structures such cholelithiasis and dystrophic
mineralization. Ultrasound is also limited by depth penetration and body confirmation which
includes overlying ribs and stomach. Additionally, volume averaging on CT can also cause
variation in measurements for the bile duct thickness similar to the gallbladder wall thickness
measurement. The last possible cause for the difference between modality measurements is the
potential time difference between studies with changes in pathology over that time window.
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There was no agreement between US and CT in the measurement of hepatic bile duct size
when the duct was identified. Hepatic ducts were the least identified biliary structure. Hepatic
ducts dilate with chronic biliary duct obstruction of at least 5-7 days duration. A possible cause
for differences in identifying the ducts and their measurements between the two modalities is the
difficulty distinguishing hepatic ducts from vessels on US. Commonly color or power Doppler is
required to differentiate the hepatic bile ducts from the hepatic vasculature. With severe hepatic
duct dilation, the hepatic ducts may also become tortuous which can help differentiate hepatic
bile ducts from the portal vasculature. Also, if the hepatic bile ducts are normal in size, they may
be too small to identify. Lastly, volume averaging on CT likely also contributes to this difference
as these are small structures which can be averaged to the surrounding hepatic parenchyma.
Patients with hypoattenuating bile had diagnoses consistent with previously reported
pathologies including cholangitis, extrahepatic biliary outflow obstruction, and gallbladder wall
mass. Hypoattenuating bile is caused by any pathology which decreases the ability of the
gallbladder to absorb fluid to further concentrate the bile. This therefore leads to increased fluid
attenuation of the bile.
Although beyond the initial investigative purpose of this project, the comparison of US
and CT diagnosis of hepatitis was evaluated as the hepatic system is intimately related to the
biliary system. There was poor agreement of US and CT to the final clinical diagnosis of
hepatitis with many false positives and negatives. This is not an unexpected finding as hepatitis
is difficult to diagnose on each modality. A previous study found 64% of sonographically
normal livers had histologic abnormalities.88 A liver with acute hepatitis on US appears enlarged
and hypoechoic. A liver with chronic hepatitis with cirrhosis and fibrosis appears small and
lobulated with hyperechoic striations on US. Acute hepatitis on CT also appears enlarged with
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increased arterial contrast enhancement with hypervascular inflammation. There may also be
regions of decreased contrast enhancement in areas of necrosis. Computed tomographic
appearance of chronic hepatitis is a small and lobulated liver with noncontrast enhancing
striations consistent with cirrhosis and fibrosis. The liver may also be normal one either
modality and cytology or histopathology is requited for definitive diagnosis. False positives of
hepatitis were also common in this group of canine patients. Not all of the included cases had
liver cytologic and/or histopathologic diagnoses which is a limiting factor in confirming if the
diagnostic imaging diagnosis of hepatitis was correct.
There was no significant difference with poor agreement between the proportions that
were positive and negative on US and CT in the identification of the pancreatitis. There was a
significant difference with moderate agreement between the proportions that were positive and
negative on US identifying pancreatitis. This is consistent with previous literature with one
study determining a sensitivity 68% of US to identify acute pancreatitis.89,90 No pancreatic
cytologic and/or histopathologic diagnoses were obtained which may lead to false negative or
false positive pancreatitis diagnoses as these cases were determined to be positive for pathology
if there were changes present on US, blood work changes consistent with pancreatitis (most
commonly elevated canine lipase [SNAP cPLI] or specific canine pancreatic lipase [Spec
cPL/cPLI]), or physical exam findings in correlation with the clinical history. Canine lipase has
a lower specificity (50-78%) and a relatively high sensitivity (74-100%) for pancreatitis but can
result in many false positives.90 The manufacturer states that a positive SNAP test (IDEXX
Laboratories, Inc) must be confirmed by measuring Spec cPL because the SNAP test is abnormal
for dogs in the equivocal zone of 200 to 400 μg/L.90 Ultrasound can help with this diagnosis as a
previous study of 157 dogs found when only one of pancreatic enlargement, altered pancreatic
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echogenicity or hyperechoic mesentery was identified, the sensitivity was high at 89% but
specificity was low at 43% for diagnosing pancreatitis.91 When all three changes were
identified, the sensitivity and specificity were 43% and 92%, respectively.
The ultrasonographic appearance of acute pancreatitis includes changes such as
pancreatic thickening, hypoechoic pancreas, pancreatic edema, hyperechoic peripancreatic
mesentery, and peritoneal effusion. The pancreas may also have hypoechoic nodules in regions
of necrosis or abscessation. Focal functional small intestinal ileus and gastritis can occur due to
local inflammation. Severe pancreatitis can also cause extrahepatic biliary duct obstruction with
additional findings consistent with previously described changes. The ultrasonographic
appearance of chronic pancreatitis in dogs includes pancreatic thickening, heterogeneous
hyperechogenicity, and less peripancreatic hyperechoic mesentery due to decreased active
peripancreatic peritonitis. The pancreas again can appear normal in cases with acute or chronic
pancreatitis.
There was no significant difference with good agreement between the proportions that
were positive and negative on CT in identifying pancreatitis. This is not unexpected as a
pancreas with acute and chronic pancreatitis can appear normal on CT. Canine acute pancreatitis
changes included pancreatic thickening, increased contrast enhancement with
hypervascularization, hypoattenuating postcontrast if necrotizing, pancreatic edema, and illdefined borders. There may also be increased contrast enhancement of peripancreatic mesentery
and peritoneal effusion due to surrounding peritonitis and steatitis. Noncontrast enhancing
nodules may be present in regions of focal necrosis or abscessation. Lastly, similar to the
ultrasonographic changes, concurrent focal functional small intestinal ileus, gastritis, and
extrahepatic biliary duct obstruction may also be present. The CT changes consistent with
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chronic pancreatitis include pancreatic thickened and heterogeneous hypoattenuation due to lipid
replacement and fibrosis.
In conclusion, CT was more accurate at identifying cholelithiasis than US. No statistical
difference was identified in the odds to identify other biliary pathology between US and CT in
these canine patients presenting for acute abdominal signs.
The clinical implications of this research can help determine if a clinician should use US
or CT when working up a canine patient presenting for acute abdominal signs that are suspected
to be of biliary origin. Ultrasound can be a great first diagnostic imaging modality for these
patients as it shows great parenchymal detail, has increased sensitivity for finding small volume
peritoneal effusion, and has no significant difference in the ability to detect pathology in canine
patients <25 kg.9 Ultrasound is less expensive than CT and may be able to obtain more
information in patients who are dehydrated and cannot receive intravenous contrast due to the
risk of acute kidney failure. However, US is very limited by the sonographer’s comfort level and
skill in being able to evaluate intraabdominal structures, especially the hepatobiliary tract due to
location and limitations of beam penetration to these deep structures. Numerous studies
comparing CT to US for various abdominal pathologies has shown CT having no significant
difference or improved identification of intraabdominal pathology including canine gastric
neoplasia, canine surgical cases presenting for acute abdominal signs, and canine patients >25
kgs. 6,9,43 The results of this study were consistent with this conclusion in addition to CT having
increased identification of mineral attenuating structures. Additional benefit to CT is increased
tomographic evaluation of deeper anatomical structures and limited training required for study
acquisition. Computed tomography studies can be sent to a remote radiologist for interpretation
which allows for a better global view of the pathology than US studies submitted for review by a
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sonographer not comfortable in biliary evaluation. This benefit of CT is often worth the tradeoff
of exposure to ionizing radiation as the medical management or surgical intervention can be
pursued sooner. There is low risk for adverse events in the medical use of radiation for this type
of CT study in dogs.
With the findings of this study, it would be very reasonable for a hospital to continue
using US as the gold standard for imaging in canine patients (especially those <25 kg) presenting
for acute abdominal signs with concerns for biliary pathology when a clinician, sonographer, or
radiologist comfortable in imaging the biliary system is available. In facilities where CT is
available, when a sonographer is unavailable, or when there is a high concern for cholelithiasis,
CT is likely a better first choice for an imaging modality.
Limitations
The main limitation of this study is the limited sample population and under powering of
this study, which may have resulted in a Type II error. A type II error occurs when one fails to
reject the null hypothesis that is actually false producing a false negative. As in this study, the
type II error may cause the false impression that CT is equivalent to US to identify biliary
pathology in these dogs. Our sample size is smaller than expected due to the COVID pandemic
and subsequent hospital shutdowns and decreased patient numbers. The acquired sample size
was only 35 of the originally calculated 60 from the power calculation (28 positive and 7
negative). A larger sample size would help to confirm these findings.
An additional limitation is the lack of standardization of sedation protocols. Different
protocols may have an effect on the CT or US appearance of the gallbladder wall or duct size.
The majority of the patients received dexmedetomidine as part of their sedation protocol. A
recent publication revealed dexmedetomidine used in canine patients causes gallbladder wall
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edema in 24% of systemically healthy client-owned dogs (n=79).59 While the use of
dexmedetomidine may have caused gallbladder wall edema, it was not a common finding in this
population of dogs and was likely clinically insignificant. The two patients with the primary
finding being gallbladder wall edema had pathologies consistent with formation of gallbladder
wall edema which included anaphylaxis and protein losing enteropathy with concurrent
pancreatic edema.
An additional limitation is the lack of histopathology in all patients and within all regions
of the biliary tract. Lack of histopathological diagnosis in all imaged regions may have revealed
no true pathology in regions which appeared abnormal on the imaging modalities or confirmed
pathology in false negative cases. This may be particularly relevant in the patient within this
study where the bile duct was dilated on the CT study but not on US. Sampling all regions of
interest in these patients is not ethical and thus was not performed.
A fourth limitation was that it was difficult for the 2 examiners (a board-certified
radiologist and a radiology resident) to be truly blinded to all studies due to small size of the
service. The studies were anonymized and randomized to limit this, but certain cases may have
been memorable, such as the single gallbladder wall mass.
Future Studies
Future work from this project can stem in two directions. In one direction, future work
stemming from this project can include a more detailed description of various biliary diseases in
larger numbers of animals. This can include gallbladder mucoceles (both intact and ruptured),
biliary neoplasia, cholelithiasis, and cholecystitis. In addition, future work can explore the CT
appearance of biliary disease in feline patients. In the other direction, future work comparing the
performance of CT to US in acute abdominal canine patients for other diseases, including
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splenic, hepatic, gastrointestinal, pancreatic, and urogenital diseases, can be investigated. The
ultimate goal is to determine if CT is as accurate or more accurate in diagnosing these
pathologies in canine patients compared to abdominal US. If so, this could allow for patients to
be diagnosed and treated more quickly and would allow for personnel without extensive US
experience to obtain a diagnosis quickly and accurately. These factors would clearly benefit
these patients greatly, especially when treatments or surgery can be initiated more quickly (in
some cases, hours earlier). Magnetic resonance imaging can also be explored to replace CT as
the primary way for tomographic evaluation of the biliary system in canine patients in
nonemergent cases as it is being used in human medicine.
Synopsis
This study did not detect a difference in the ability of contrast-enhanced dual phase
abdominal CT and US to identify biliary pathology in patients presenting for acute abdominal
signs. This study also found that CT was better at identifying cholelithiasis than US. These
findings suggest CT may be able to be used in place of US if a clinician confident in US is
unavailable which may hasten decision making (whether surgical or medical) in canine patients
presenting for acute abdominal signs of biliary origin, especially those with cholelithiasis.
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